{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":56,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":56,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"ac4ca2444aff","filters":{"venue":"Drugs in R&D"}},"results":[{"id":"W2751648725","doi":"10.1007/s40268-017-0207-7","title":"Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Benzodiazepine; Adverse effect; Intensive care medicine; Dementia; Psychiatry; Harm; Disease; Pharmacology; Psychology; Internal medicine","authors":[{"name":"Jaden Brandt","is_ca":true},{"name":"Christine Leong","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6375684566135268,"gpt":0.6246672980506429,"spread":0.01290115856288387,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01006721,0.0004514178,0.004200117,0.0007283173,0.0000675104,0.00001155198,0.0004035449,0.0004085165,0.0002573902],"category_scores_gemma":[0.01130919,0.0002939056,0.0003618157,0.0005250415,0.0002769225,0.0001942295,0.0002225236,0.001828592,0.00005042487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001606421,"about_ca_system_score_gemma":0.0003077519,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002296823,"about_ca_topic_score_gemma":0.0000176044,"domain_scores_codex":[0.9937893,0.002196207,0.002121869,0.0007565184,0.0006009718,0.0005351687],"domain_scores_gemma":[0.9940457,0.002926477,0.001273582,0.001327917,0.0001680856,0.0002582785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001652039,0.0007217469,0.02370577,0.1873708,0.0002733211,0.000401029,0.0001650911,1.668204e-7,2.056165e-7,0.0004724549,0.002364318,0.7843599],"study_design_scores_gemma":[0.0009575502,0.0002191555,0.004755533,0.1335237,0.0005754699,0.00002875144,0.00005527478,0.00001696546,4.45094e-7,0.0001214658,0.8594828,0.0002628854],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001008082,0.9882733,9.399665e-8,0.001519007,0.0002195086,0.002713657,0.00005222288,0.00002387422,0.006190216],"genre_scores_gemma":[0.000541269,0.9969026,0.0001300077,0.001021575,0.00006237665,0.0001353027,0.0005566883,0.00004238266,0.0006077296],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8571185,"threshold_uncertainty_score":0.9999513,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2556835195","doi":"10.1007/s40268-016-0153-9","title":"A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI","year":2016,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; McGill University","funders":"","keywords":"Sialorrhea; Salivary gland; Medicine; Oral medicine; Dentistry; Dermatology; Internal medicine; Surgery","authors":[{"name":"Ändy Wolff","is_ca":false},{"name":"Revan Kumar Joshi","is_ca":false},{"name":"Jørgen Ekström","is_ca":false},{"name":"Doron J. Aframian","is_ca":false},{"name":"Anne Marie Lynge Pedersen","is_ca":false},{"name":"Gordon Proctor","is_ca":false},{"name":"Nagamani Narayana","is_ca":false},{"name":"Alessandro Villa","is_ca":false},{"name":"Ying Wai Sia","is_ca":true},{"name":"Ardita Aliko","is_ca":false},{"name":"Richard McGowan","is_ca":false},{"name":"Alexander Ross Kerr","is_ca":false},{"name":"Siri Beier Jensen","is_ca":false},{"name":"Arjan Vissink","is_ca":false},{"name":"Colin Dawes","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0271903309366712,"gpt":0.3502844291157385,"spread":0.3230940981790673,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002252914,0.000644334,0.003294762,0.0007307924,0.0002382715,0.00002911197,0.0003001155,0.0002691761,0.0003331063],"category_scores_gemma":[0.00316952,0.0003188683,0.000274181,0.001903919,0.0002145297,0.00007376388,0.0001056374,0.0007542771,0.0001806959],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000377898,"about_ca_system_score_gemma":0.0003735884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003168575,"about_ca_topic_score_gemma":0.0002579388,"domain_scores_codex":[0.9957785,0.0007601684,0.001617023,0.0007895075,0.0006068138,0.0004479649],"domain_scores_gemma":[0.9946119,0.003211892,0.0005327984,0.00115284,0.0001533163,0.0003372151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002073706,0.0002594551,0.0001109764,0.4109089,0.0008876089,0.00003435081,0.0009403416,2.465736e-7,5.97455e-7,0.0006534475,0.4712543,0.1147424],"study_design_scores_gemma":[0.0008579785,0.0001031135,0.00003570371,0.5175644,0.002610213,0.000120205,0.0002495248,0.000001830205,6.185322e-8,0.00003280106,0.47818,0.0002441967],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001175181,0.9767465,0.0001757534,0.008214578,0.0005900896,0.005877584,0.00009062466,0.00008089785,0.008212227],"genre_scores_gemma":[0.00004506446,0.9805577,0.00005762994,0.004877347,0.0004008515,0.002045082,0.0003144761,0.0000867099,0.01161519],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1144982,"threshold_uncertainty_score":0.9999263,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011049230","doi":"10.2165/00126839-200809050-00002","title":"Applications of Metabolomics in Drug Discovery and Development","year":2008,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":241,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Genome Alberta","keywords":"Metabolomics; Drug discovery; Drug development; Identification (biology); Biomarker discovery; Pharmaceutical industry; Data science; Computational biology; Drug; Computer science; Biochemical engineering; Medicine; Pharmacology; Bioinformatics; Biology; Proteomics; Engineering","authors":[{"name":"David S. Wishart","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01503816838159423,"gpt":0.2875014690859529,"spread":0.2724633007043586,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001696898,0.000227154,0.0008762953,0.0002251669,0.00002621768,0.000007559761,0.0001820799,0.000145406,0.000001494799],"category_scores_gemma":[0.00002602446,0.0001986031,0.00009327477,0.0002287218,0.00008314006,0.000002637939,0.0002423049,0.0001398209,0.000001713669],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002500998,"about_ca_system_score_gemma":0.0002030112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002495626,"about_ca_topic_score_gemma":0.00008860895,"domain_scores_codex":[0.9988013,0.00005277551,0.000523196,0.0003677348,0.00007916288,0.000175825],"domain_scores_gemma":[0.9994678,0.00002973175,0.0001949686,0.0002625068,0.00001859235,0.00002636135],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000008402571,0.0001601312,0.0003269365,0.002852422,0.0001978224,0.00000206403,0.0002643073,0.00000136686,0.00006560107,0.0011953,0.0003544953,0.9945711],"study_design_scores_gemma":[0.0001561169,0.000006197317,0.00007214838,0.0002452579,0.00002599076,0.000005654579,0.00006216641,1.8925e-7,0.0002145775,0.00002782589,0.9989924,0.0001915142],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001683952,0.997036,0.0001320329,0.000004427471,0.00004756045,0.0004343769,0.00003657531,0.000001999751,0.0006230868],"genre_scores_gemma":[0.0004659415,0.9966112,0.002030501,0.00001010616,0.0000459656,0.0002629177,0.0001675097,0.00002144485,0.0003844331],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9986379,"threshold_uncertainty_score":0.8098801,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W8127528","doi":"10.2165/00126839-200708060-00003","title":"Improving Early Drug Discovery through ADME Modelling","year":2007,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":133,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"ADME; Drug development; Drug discovery; Drug; Risk analysis (engineering); Computer science; Pharmacology; Biochemical engineering; Medicine; Intensive care medicine; Bioinformatics; Engineering; Biology","authors":[{"name":"David S. Wishart","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08703858291226216,"gpt":0.3781868798061028,"spread":0.2911482968938407,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00204096,0.0006906819,0.001576492,0.0005911188,0.0001182134,0.0006916929,0.002618215,0.0002870332,0.000004321023],"category_scores_gemma":[0.00008606858,0.0006420476,0.0006413253,0.001672101,0.00007808125,0.002518429,0.001232879,0.001092026,0.0001146329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004944246,"about_ca_system_score_gemma":0.0007963039,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004960941,"about_ca_topic_score_gemma":0.000009568084,"domain_scores_codex":[0.9951817,0.0005689567,0.001266304,0.001349717,0.0008389579,0.000794342],"domain_scores_gemma":[0.9960051,0.00200401,0.0005762726,0.00123331,0.00007311543,0.0001081986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000001882226,0.00005154674,0.000001108069,0.002457484,0.00002861119,0.00004095847,0.0011571,0.02007615,2.613921e-8,0.03806142,0.00005281809,0.9380709],"study_design_scores_gemma":[0.0002852211,0.00002342588,0.000003686965,0.009355417,0.00009965599,0.00003879428,0.00004341542,0.2116372,0.000003110179,0.02333008,0.7537339,0.001446083],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001936663,0.5021253,0.4953457,0.0000136444,0.0007659966,0.0003563331,0.00001044193,0.00009529402,0.001267895],"genre_scores_gemma":[0.00003757732,0.7783046,0.2205484,0.00008413481,0.0003191683,0.00006743969,0.00002903608,0.00007499855,0.0005346289],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9366248,"threshold_uncertainty_score":0.9996031,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2051962629","doi":"10.1007/s40268-015-0082-z","title":"mTOR: A Potential Therapeutic Target in Osteoarthritis?","year":2015,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"PI3K/AKT/mTOR pathway; Osteoarthritis; Cartilage; Medicine; Cancer research; Inflammation; Cell biology; Bioinformatics; Internal medicine; Pathology; Signal transduction; Biology; Anatomy","authors":[{"name":"Bandna Pal","is_ca":true},{"name":"Helal Endisha","is_ca":true},{"name":"Yue Zhang","is_ca":true},{"name":"Mohit Kapoor","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02481238498216827,"gpt":0.3256945292484221,"spread":0.3008821442662538,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005252381,0.0004001632,0.0009006741,0.000167068,0.00002047417,0.00003144463,0.0005017013,0.0006584791,0.00005732305],"category_scores_gemma":[0.00003702789,0.0003879993,0.0002729392,0.0002316623,0.0000825469,0.000003477151,0.0001747667,0.000425028,0.00006813392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001543174,"about_ca_system_score_gemma":0.0006169559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002855002,"about_ca_topic_score_gemma":0.00003613181,"domain_scores_codex":[0.9978893,0.0002579818,0.0005496317,0.000628442,0.0002400132,0.0004346646],"domain_scores_gemma":[0.999097,0.00001562019,0.0001892134,0.0005591903,0.00005186256,0.00008705647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003112176,0.00007942627,0.00002406805,0.001325841,0.00006623113,0.00004706535,0.00008388958,0.0000351228,0.0002051209,0.00002269828,0.001847004,0.9962324],"study_design_scores_gemma":[0.0006179616,0.0001295092,0.000002158475,0.001673833,0.00005286834,0.00002860663,0.0000217297,0.000005047541,0.00009756128,0.0001413368,0.9968042,0.0004251784],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002280127,0.9967479,0.00004005761,0.00001297889,0.0008387942,0.0005148718,0.00009058489,0.00001323861,0.001513602],"genre_scores_gemma":[0.001704582,0.9959463,0.0002546097,0.0001007177,0.0006768936,0.0002377146,0.0004995164,0.00009247485,0.0004871581],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9958072,"threshold_uncertainty_score":0.9998572,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W139570440","doi":"10.2165/00126839-200607020-00001","title":"Selective Phosphodiesterase (PDE)-4 Inhibitors","year":2006,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Neuroinflammation; Neuroprotection; Phosphodiesterase; Neuroscience; Disease; Medicine; Amyloid (mycology); Cyclic adenosine monophosphate; Microglia; Pharmacology; Alzheimer's disease; Psychology; Internal medicine; Biology; Enzyme; Inflammation; Biochemistry; Pathology; Receptor","authors":[{"name":"Afshin Ghavami","is_ca":true},{"name":"Warren D. Hirst","is_ca":true},{"name":"Thomas J. Novak","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01316560028924786,"gpt":0.293421831570008,"spread":0.2802562312807602,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001868232,0.0004141125,0.0006984979,0.0001678268,0.00006354424,0.00003435112,0.0001715382,0.0005486752,0.00001576731],"category_scores_gemma":[0.00003902912,0.00036091,0.0003444586,0.0003049304,0.00007276316,0.000004409686,0.0001077974,0.0002726278,0.00005146357],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001152587,"about_ca_system_score_gemma":0.0002060381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000567792,"about_ca_topic_score_gemma":0.00007043795,"domain_scores_codex":[0.998277,0.0001432884,0.0005444653,0.0005807422,0.0001515058,0.0003029726],"domain_scores_gemma":[0.999227,0.00002820887,0.0002479116,0.0003804419,0.00005418909,0.00006219287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004502009,0.0002035938,0.0001438897,0.003279801,0.0001442166,0.00001181403,0.0001105965,0.00005129842,0.00005843299,0.00005375444,0.04926332,0.9466342],"study_design_scores_gemma":[0.0002775573,0.0000520271,0.00003116622,0.001362925,0.00006953453,0.00001332381,0.00001489015,0.000003658863,0.0004507586,0.00002057776,0.9972969,0.0004066416],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003500361,0.9942874,0.00004092753,0.000009632055,0.0008174594,0.0005143519,0.00004066204,0.00002487355,0.003914616],"genre_scores_gemma":[0.0004057307,0.992777,0.00009692449,0.0000638309,0.0005593062,0.0001588041,0.001410364,0.00006689749,0.004461144],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9480336,"threshold_uncertainty_score":0.9998843,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2072492830","doi":"10.2165/00126839-200809030-00001","title":"A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases","year":2008,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":58,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; CpG Oligodeoxynucleotide; Toll-like receptor; Immunology; DNA vaccination; Pharmacology; Immune system; Biology; Innate immune system; Immunization; Gene; Genetics","authors":[{"name":"Kaveri Gupta","is_ca":true},{"name":"Curtis Cooper","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008426552575936072,"gpt":0.2615718066041785,"spread":0.2531452540282425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003419141,0.0002720574,0.001321305,0.0003205879,0.00004101327,0.000003635827,0.0002328416,0.0002465447,0.00006934997],"category_scores_gemma":[0.0002010952,0.0001841849,0.0001549302,0.0004800069,0.00009792292,0.00004771315,0.0001200049,0.0003791619,0.000033251],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001450646,"about_ca_system_score_gemma":0.000554609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001128661,"about_ca_topic_score_gemma":0.00004544463,"domain_scores_codex":[0.9975394,0.0008762292,0.001076845,0.0002428581,0.00005030201,0.0002143596],"domain_scores_gemma":[0.9988228,0.0002577764,0.0005508386,0.0003160897,0.00004295048,0.000009526575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008607005,0.0002255014,0.00125576,0.03113158,0.0001207329,0.000002187088,0.0008502664,4.692143e-7,0.0002159424,0.0001209405,0.00004329288,0.9659473],"study_design_scores_gemma":[0.0007067381,0.00007042976,0.002406596,0.07453814,0.0001155819,0.00008061708,0.00005767838,2.579937e-7,0.001014138,0.00008384558,0.9206709,0.0002550847],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02778396,0.9706857,1.034528e-7,0.00002308184,0.0001504184,0.00114778,0.000005558139,0.000008012419,0.0001954136],"genre_scores_gemma":[0.02477685,0.9747505,0.000005106177,0.00005545477,0.00000553951,0.0002397776,0.00004437414,0.00002003562,0.0001023855],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9656922,"threshold_uncertainty_score":0.7510843,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117988243","doi":"10.2165/11593390-000000000-00000","title":"Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"Shionogi; Astellas Pharma; Purdue University; Eisai; Bayer HealthCare; Boston Scientific Corporation; Purdue Pharma; Gilead Sciences; GlaxoSmithKline; Nevro; Teva Pharmaceutical Industries; AstraZeneca; Pfizer","keywords":"Euphoriant; Naltrexone; Morphine; Medicine; Heroin; Opioid; Anesthesia; Narcotic antagonist; Visual analogue scale; Pharmacology; Drug; Internal medicine; Psychiatry","authors":[{"name":"Lynn R. Webster","is_ca":false},{"name":"Franklin K. Johnson","is_ca":false},{"name":"Joseph Stauffer","is_ca":false},{"name":"Beatrice Setnik","is_ca":false},{"name":"Sabrina Ciric","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0124207090589173,"gpt":0.2684139299841857,"spread":0.2559932209252684,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002231793,0.0003848311,0.0007180068,0.0005730577,0.00003765472,0.00001230846,0.0001743458,0.0001494379,0.0001559254],"category_scores_gemma":[0.00007768692,0.0003244825,0.0001136441,0.0004730875,0.00008949805,0.00009912463,0.00007929846,0.0003847095,0.00002409319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005058937,"about_ca_system_score_gemma":0.0001972482,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01069556,"about_ca_topic_score_gemma":0.0002278123,"domain_scores_codex":[0.9979134,0.0000945924,0.0005000094,0.0005448883,0.0004034341,0.0005436448],"domain_scores_gemma":[0.9989283,0.0001242067,0.0001655014,0.000522072,0.00004928935,0.000210636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002773086,0.009903467,0.6413534,0.0008197724,0.0003791444,0.002157336,0.2890044,0.00008310922,0.02094052,0.000642423,0.0001057847,0.03183751],"study_design_scores_gemma":[0.006682643,0.003411312,0.9467455,0.0006546377,0.00007420383,0.0000942401,0.004186672,0.0001268874,0.03733695,0.0003262626,0.000004511252,0.0003561756],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968446,0.000475852,0.000006498776,0.00004217097,0.0002527583,0.001144436,0.000009789041,0.00003767024,0.001186202],"genre_scores_gemma":[0.998722,0.0002548173,0.0006060619,0.00006198016,0.00004553242,0.0001490096,0.00001999325,0.00005329014,0.00008729783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3053921,"threshold_uncertainty_score":0.9999207,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3173963108","doi":"10.1007/s40268-021-00351-6","title":"Potential for the Repurposing of Adamantane Antivirals for COVID-19","year":2021,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Amantadine; Memantine; Coronavirus; Rimantadine; Virology; Drug repositioning; Pharmacology; Viral replication; Biology; Virus; Receptor; Medicine; NMDA receptor; Influenza A virus; Drug; Biochemistry; Coronavirus disease 2019 (COVID-19); Disease","authors":[{"name":"Roger F. Butterworth","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1160359683892616,"gpt":0.4612790641218202,"spread":0.3452430957325585,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001654644,0.0003093684,0.001875625,0.0003044487,0.0001125295,0.00003856338,0.0003977975,0.000322396,0.00001191839],"category_scores_gemma":[0.002011886,0.0002046303,0.001025092,0.0005356091,0.0001564769,0.0000382048,0.0001474765,0.0004056113,0.000004799051],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002614703,"about_ca_system_score_gemma":0.002379121,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001157368,"about_ca_topic_score_gemma":0.00001615058,"domain_scores_codex":[0.997558,0.0001604542,0.0008341672,0.000541085,0.0004499811,0.0004563145],"domain_scores_gemma":[0.9962671,0.002431012,0.0003220924,0.000736373,0.000197085,0.00004629584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002128655,0.0001751654,0.00002935523,0.06413417,0.0004210325,0.000103354,0.0002892234,7.079651e-7,0.0001006299,0.0006195322,0.003980696,0.9299332],"study_design_scores_gemma":[0.001254379,0.0001281773,0.000001276813,0.007538907,0.0009412927,0.00009064891,0.0002300139,0.0001308514,0.0003260225,0.0001121754,0.9890573,0.000188958],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007531511,0.9919876,0.002280056,0.0003116927,0.0003611971,0.004480129,0.0001913115,0.00002475041,0.0002879757],"genre_scores_gemma":[0.00008920614,0.9897472,0.0007406278,0.00719046,0.0006047582,0.001162989,0.0001188013,0.00009681857,0.0002491054],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9850766,"threshold_uncertainty_score":0.8344582,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2603821422","doi":"10.1007/s40268-017-0180-1","title":"Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Windsor","funders":"Canadian Cancer Society Research Institute","keywords":"Cyclin-dependent kinase; Glioma; Glioblastoma; Repurposing; Disease; Medicine; Population; Biology; Bioinformatics; Cancer research; Cancer; Cell cycle; Internal medicine","authors":[{"name":"Dorota Lubanska","is_ca":true},{"name":"Lisa A. Porter","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08373018955416103,"gpt":0.4042266653883339,"spread":0.3204964758341728,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001827059,0.0004387038,0.002748536,0.0003741226,0.00006965231,0.000020639,0.0001187959,0.0002596256,0.00001884277],"category_scores_gemma":[0.0001491532,0.0002963517,0.001031242,0.0001241216,0.00005478796,0.00003924813,0.00003546013,0.0000696704,0.00003173265],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005001179,"about_ca_system_score_gemma":0.0002047023,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007710794,"about_ca_topic_score_gemma":0.00001294215,"domain_scores_codex":[0.9981998,0.00003730076,0.0008370584,0.000419598,0.0001867247,0.0003195334],"domain_scores_gemma":[0.9980963,0.0003481278,0.0007007832,0.0006787439,0.00006995606,0.0001060388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003075294,0.0004825912,0.0002513142,0.01341174,0.0002682749,0.00006360699,0.0001580109,1.94492e-7,5.21967e-7,0.00004517821,0.0001216646,0.9851661],"study_design_scores_gemma":[0.002602809,0.0006730176,0.00005128638,0.04200732,0.0015839,0.00003992613,0.00004007426,0.000009804572,0.0001254589,0.000008647438,0.9526526,0.0002051335],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00120843,0.9947694,7.87478e-7,0.00005992435,0.0002395378,0.00280624,0.0001404555,0.00002184257,0.000753411],"genre_scores_gemma":[0.00121526,0.9961106,0.0006043549,0.000005699495,0.0004634271,0.001124226,0.0001793979,0.00006732991,0.0002296848],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.984961,"threshold_uncertainty_score":0.9999489,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024058161","doi":"10.2165/11537800-000000000-00000","title":"MicroRNA: Potential Targets for the Development of Novel Drugs?","year":2010,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"microRNA; Biology; Epigenetics; Regulation of gene expression; Gene regulatory network; Gene expression; Translation (biology); Gene silencing; Computational biology; Gene; Messenger RNA; Cell biology; Cancer research; Genetics","authors":[{"name":"Wei Wu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01959533176365454,"gpt":0.3033970508526896,"spread":0.2838017190890351,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004023618,0.0002725743,0.0004937318,0.00007562304,0.00006672037,0.00001399665,0.0004536865,0.0004321719,0.00001115657],"category_scores_gemma":[0.00006118118,0.0002004844,0.0003490032,0.00009032854,0.00008090721,0.000001712347,0.0001761261,0.0001751856,0.000004585642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003573287,"about_ca_system_score_gemma":0.0005314185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002754081,"about_ca_topic_score_gemma":0.00001324818,"domain_scores_codex":[0.9986222,0.0000334417,0.0006115976,0.0003675266,0.0001301241,0.0002350581],"domain_scores_gemma":[0.9989836,0.00004226068,0.0003788105,0.0004673961,0.00008645589,0.00004143871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000026862,0.0001655111,0.000001439825,0.004202472,0.0002169292,2.535278e-7,0.0001785495,0.0000125371,0.02139665,0.00004424316,0.000883478,0.9728711],"study_design_scores_gemma":[0.0003560379,0.000009370779,0.00001474894,0.0006705893,0.0001527141,0.000003528424,0.00002385795,0.00001644428,0.005596974,0.000006757134,0.9929191,0.0002299027],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007209874,0.9931827,0.004264039,0.00001487825,0.0004735713,0.001107675,0.0001442093,0.000004687312,0.00008729805],"genre_scores_gemma":[0.000971625,0.9797977,0.01636147,0.00002365532,0.0004959876,0.0004294052,0.001474784,0.00008780711,0.0003575997],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9920356,"threshold_uncertainty_score":0.8175518,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2898934370","doi":"10.1007/s40268-018-0253-9","title":"Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies","year":2018,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Cancer Institute","keywords":"Randomized controlled trial; Medicine; Budesonide; Internal medicine; Meta-analysis; Eosinophilic esophagitis; Cochrane Library; Placebo; Confidence interval; Relative risk; Adverse effect; Gastroenterology; Asthma; Pathology; Disease","authors":[{"name":"Prashanth Rawla","is_ca":false},{"name":"Tagore Sunkara","is_ca":false},{"name":"Krishna Chaitanya Thandra","is_ca":false},{"name":"Vinaya Gaduputi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06042388775615146,"gpt":0.3792141270448372,"spread":0.3187902392886857,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00803443,0.0008018724,0.04665926,0.00112612,0.0000338454,0.00001187475,0.0002307071,0.000241724,0.00003383694],"category_scores_gemma":[0.002669014,0.0003851851,0.002749715,0.001408897,0.001944434,0.00005328484,0.00009590857,0.0002119765,8.754073e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001048722,"about_ca_system_score_gemma":0.0001102314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001926174,"about_ca_topic_score_gemma":0.00005269108,"domain_scores_codex":[0.9890282,0.004318784,0.005164989,0.0006752572,0.0005429828,0.0002698412],"domain_scores_gemma":[0.9846258,0.01104768,0.002832617,0.001113082,0.0002975434,0.00008324954],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01146897,0.0004475772,0.000007065642,0.709724,0.2713844,0.00002661923,0.005607618,2.22687e-7,1.914795e-7,0.00009567882,0.00001102077,0.001226632],"study_design_scores_gemma":[0.1864423,0.0001785883,0.00001256635,0.07940019,0.7334452,0.00003899219,0.0001680723,0.00001107029,0.000002199688,0.00004100889,0.00008029107,0.0001795471],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001437643,0.9795119,0.000001719174,0.0001957605,0.00002184415,0.01857802,0.0001691531,0.000008212174,0.00007570643],"genre_scores_gemma":[0.008328246,0.9893591,0.00020655,0.00008714215,0.00001473386,0.001767658,0.0001077738,0.00004072568,0.00008805082],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6303238,"threshold_uncertainty_score":0.99986,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3085493311","doi":"10.1007/s40268-020-00322-3","title":"Nimodipine Pharmacokinetic Variability in Various Patient Populations","year":2020,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Nimodipine; Medicine; Pharmacokinetics; Subarachnoid hemorrhage; Dosing; Anesthesia; MEDLINE; Clinical significance; Intensive care medicine; Pharmacology; Internal medicine","authors":[{"name":"Sherif Hanafy Mahmoud","is_ca":true},{"name":"Xinqi Ji","is_ca":true},{"name":"Fadumo Ahmed Isse","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04794077184678272,"gpt":0.3501292232052786,"spread":0.3021884513584959,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001499468,0.0003332825,0.001228261,0.0002468926,0.00003964299,0.00001292345,0.0001441824,0.000172614,0.0002719342],"category_scores_gemma":[0.000105813,0.0002800023,0.0002554485,0.0008327691,0.00003723979,0.0000316772,0.00006838869,0.0005701881,0.0002018394],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004037419,"about_ca_system_score_gemma":0.0002346151,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001598523,"about_ca_topic_score_gemma":0.00002257111,"domain_scores_codex":[0.9980092,0.0002254427,0.0008104146,0.0004961647,0.0001992229,0.000259521],"domain_scores_gemma":[0.9991277,0.0001481157,0.0001595064,0.0004069496,0.00004176985,0.0001159045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001658969,0.0006976315,0.0002758003,0.002439712,0.00004003699,0.0001116945,0.0003361428,0.000004356048,5.332423e-7,0.00172088,0.0001962911,0.9941604],"study_design_scores_gemma":[0.000759121,0.0001151325,0.0009146038,0.002704176,0.0008100125,0.00009264246,0.00001351916,0.0004385881,5.226535e-7,0.001162776,0.9926879,0.0003009707],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002506422,0.9873139,0.00009416478,0.0008333779,0.0003304025,0.002805036,0.00009473655,0.00009289032,0.00818482],"genre_scores_gemma":[0.007482124,0.9891906,0.001222129,0.0002035903,0.0001962072,0.0007600678,0.0007556612,0.00005166853,0.0001379676],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9938594,"threshold_uncertainty_score":0.9999652,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3156032412","doi":"10.1007/s40268-021-00345-4","title":"Ammonia Removal by Metabolic Scavengers for the Prevention and Treatment of Hepatic Encephalopathy in Cirrhosis","year":2021,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Hyperammonemia; Urea cycle; Hepatic encephalopathy; Lactulose; Cirrhosis; Internal medicine; Ornithine; Chemistry; Phenylbutyrate; Medicine; Endocrinology; Biochemistry; Pharmacology; Arginine; Amino acid","authors":[{"name":"Roger F. Butterworth","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03239207941204482,"gpt":0.3379310956392957,"spread":0.3055390162272509,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001621225,0.0001598229,0.000853538,0.0001190011,0.00001746186,0.000006635568,0.00004041236,0.00008550073,0.000008212905],"category_scores_gemma":[0.00000854366,0.0001044747,0.0002322678,0.0002121411,0.00003103843,0.00003086652,0.000005392282,0.00005908137,9.330071e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007145192,"about_ca_system_score_gemma":0.0001613223,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001982001,"about_ca_topic_score_gemma":0.00005580202,"domain_scores_codex":[0.999079,0.0001151162,0.0003609549,0.0002134356,0.0001171749,0.0001143571],"domain_scores_gemma":[0.999415,0.0002463446,0.0001224452,0.0001615899,0.00002064531,0.00003392582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003285982,0.0002399396,0.0004873236,0.006691589,0.0003649544,0.00001971751,0.001255227,2.5518e-7,0.000002275641,0.00005204633,0.000007697406,0.9908461],"study_design_scores_gemma":[0.0121339,0.001008868,0.006814456,0.08227878,0.05397087,0.0001490999,0.001704135,0.0002367246,0.0003725023,0.0002452367,0.8402282,0.0008572268],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01217555,0.9861087,0.00001667279,0.00002430861,0.00006581884,0.001460509,0.0001055755,0.000004406687,0.00003851227],"genre_scores_gemma":[0.004466249,0.9942967,0.000177291,0.000007449669,0.00003420043,0.0004304296,0.0004707783,0.00001630944,0.0001005429],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9899889,"threshold_uncertainty_score":0.4260356,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4319332896","doi":"10.1007/s40268-023-00413-x","title":"Risk of Adverse Events Associated with Domperidone and Metoclopramide in Gastroparesis: Systematic Review and Meta-analysis","year":2023,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Domperidone; Medicine; Gastroparesis; Metoclopramide; Meta-analysis; Internal medicine; Adverse effect; Odds ratio; Placebo; Extrapyramidal symptoms; Confidence interval; Antipsychotic; Gastric emptying; Schizophrenia (object-oriented programming); Dopamine; Psychiatry; Pathology","authors":[{"name":"Daniela R. Junqueira","is_ca":true},{"name":"Dimitri Bennett","is_ca":false},{"name":"Susanna Y. Huh","is_ca":false},{"name":"Kyle Fahrbach","is_ca":false},{"name":"Binod Neupane","is_ca":true},{"name":"Marissa Betts","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05812192699939572,"gpt":0.3338852237016718,"spread":0.2757632967022761,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002193716,0.0004298314,0.009717883,0.0006827963,0.00002034094,0.000003404408,0.0001204198,0.0001166044,0.00002685715],"category_scores_gemma":[0.002921325,0.000270703,0.0008800334,0.002027303,0.0001006254,0.00004656559,0.00008194776,0.0004503322,0.000004825845],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009688407,"about_ca_system_score_gemma":0.0001076565,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003352654,"about_ca_topic_score_gemma":0.0005450866,"domain_scores_codex":[0.9963735,0.001031112,0.001460194,0.0004906823,0.0003793396,0.0002652124],"domain_scores_gemma":[0.9974399,0.0007998424,0.001074613,0.0004816544,0.00009159024,0.0001124397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00001793676,0.0001251399,0.003887792,0.9404169,0.05526032,0.00004376456,0.0001176203,0.000008636401,7.168486e-9,0.000003931308,0.000004961693,0.0001129623],"study_design_scores_gemma":[0.0004563865,0.00009241994,0.002517534,0.2147824,0.7816804,0.00002043592,0.0002464034,0.00001587865,1.250252e-8,0.00001228902,0.00003032431,0.0001455521],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009041199,0.9958512,0.000008569197,0.00004235623,0.000005042766,0.003000593,0.0001399293,0.00002172029,0.00002651314],"genre_scores_gemma":[0.001379027,0.9975042,0.000317147,0.00004168302,0.000002117412,0.0004407115,0.000106425,0.00003589307,0.0001728112],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.72642,"threshold_uncertainty_score":0.9999745,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2736936940","doi":"10.1007/s40268-017-0195-7","title":"Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"CYP2C19; CYP2C9; Pharmacogenomics; Genotyping; Phenytoin; Genotype; Medicine; Pharmacogenetics; Pharmacokinetics; Allele; Middle East; Genetics; Pharmacology; Epilepsy; Biology; Geography; Gene; Psychiatry","authors":[{"name":"Renée Dagenais","is_ca":true},{"name":"Kyle John Wilby","is_ca":false},{"name":"Hazem Elewa","is_ca":false},{"name":"Mary H. H. Ensom","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4897565503539779,"gpt":0.5137854583330572,"spread":0.02402890797907936,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001449833,0.0006882049,0.002174626,0.0003636506,0.0001468482,0.00004588607,0.0009229293,0.000625403,0.00005030782],"category_scores_gemma":[0.0001876795,0.000454885,0.000582953,0.0002803519,0.0006550312,0.00005134366,0.0002805931,0.001996142,0.00001638987],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005800262,"about_ca_system_score_gemma":0.000232072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000584597,"about_ca_topic_score_gemma":0.00003052322,"domain_scores_codex":[0.9950762,0.001896063,0.001451397,0.0006802042,0.0002733918,0.0006227338],"domain_scores_gemma":[0.9966277,0.001502598,0.0009138827,0.0006442501,0.00004674901,0.0002648422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001338539,0.0008980295,0.08179744,0.0009864542,0.0004811782,0.0001399807,0.002472167,0.00002447345,0.000001375139,0.00004210713,0.0005673802,0.9124556],"study_design_scores_gemma":[0.004167718,0.0003332861,0.1047869,0.00110229,0.002218266,0.00009507204,0.00009348697,0.0003691931,0.000001415659,0.0001522232,0.885859,0.0008211432],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1901387,0.8065779,0.000001019923,0.00007058557,0.0007444511,0.001112688,0.0002350611,0.0000116656,0.001107862],"genre_scores_gemma":[0.109915,0.889289,0.00004167818,0.0001753267,0.0002831294,0.00008629262,0.00002558206,0.00005513274,0.0001289241],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9116344,"threshold_uncertainty_score":0.9997903,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2919757880","doi":"10.1007/s40268-019-0263-2","title":"Ulcerative Colitis: Shifting Sands","year":2019,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Pfizer","keywords":"Medicine; Ulcerative colitis; Disease; Inflammatory bowel disease; Quality of life (healthcare); Proctitis; Internal medicine; Colitis; Intensive care medicine; Gastroenterology","authors":[{"name":"Geert D’Haens","is_ca":false},{"name":"James O. Lindsay","is_ca":false},{"name":"Remo Panaccione","is_ca":true},{"name":"Stefan Schreiber","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02149741843679606,"gpt":0.3160678775912923,"spread":0.2945704591544963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002761141,0.0003265417,0.0006223063,0.00008794481,0.00003530449,0.00003213403,0.0003024701,0.000407569,0.00005294351],"category_scores_gemma":[0.00007137997,0.0003095872,0.0003017662,0.00009662959,0.00005019103,0.000002501545,0.0001800986,0.0002408153,0.0002311929],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006380784,"about_ca_system_score_gemma":0.0004462747,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007988785,"about_ca_topic_score_gemma":0.0000301635,"domain_scores_codex":[0.9984164,0.000232502,0.0004091698,0.0005060247,0.0001230643,0.0003128534],"domain_scores_gemma":[0.9991568,0.00002673787,0.0001879601,0.0005154576,0.00003846521,0.00007452995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001235851,0.0001067271,0.0002510784,0.02523793,0.0003431579,0.0002427957,0.0004439832,0.00001195864,0.000005079607,0.001190061,0.006201713,0.9658419],"study_design_scores_gemma":[0.000250512,0.00001877516,0.0002927035,0.002681851,0.000105824,0.000006527386,0.00004066264,0.000003353583,0.000005304088,0.00001549419,0.9961987,0.0003802865],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008230197,0.9848055,0.000006180288,0.000002817298,0.0003339455,0.0006722165,0.00009310195,0.00001335436,0.01324981],"genre_scores_gemma":[0.0004122568,0.9963924,0.00006845054,0.00007709385,0.0004031501,0.0001652639,0.0006576843,0.00006873462,0.001754923],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.989997,"threshold_uncertainty_score":0.9999356,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976165878","doi":"10.2165/11593140-000000000-00000","title":"Impact of Respiratory Syncytial Virus","year":2011,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Respiratory viral infections research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; Jewish General Hospital; Children's Hospital of Winnipeg; Mount Sinai Hospital","funders":"","keywords":"Palivizumab; Medicine; Transmission (telecommunications); Respiratory tract infections; Virus; Intensive care medicine; Disease; Infection control; Pediatrics; Health care; Respiratory system; Immunology; Internal medicine","authors":[{"name":"Marianne Bracht","is_ca":true},{"name":"Debbie Basevitz","is_ca":true},{"name":"Marilyn Cranis","is_ca":true},{"name":"Rose Paulley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1664323907710402,"gpt":0.4867733928526308,"spread":0.3203410020815906,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007706957,0.0003909369,0.002166587,0.001354984,0.00002924995,0.00001151552,0.0002949797,0.0005349895,0.001199331],"category_scores_gemma":[0.0003653185,0.0002845157,0.001005331,0.001045858,0.0002102487,0.0000813271,0.0001413249,0.001122573,0.0005615611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007340763,"about_ca_system_score_gemma":0.001955017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006046254,"about_ca_topic_score_gemma":0.00001742077,"domain_scores_codex":[0.9973875,0.000396512,0.001014451,0.0004260457,0.0003574435,0.0004180116],"domain_scores_gemma":[0.9982489,0.0001595344,0.0003128697,0.0009480468,0.0001422457,0.0001883766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006453449,0.0003540954,0.0009857434,0.01025604,0.0002834664,0.0000687862,0.00008133843,4.133113e-7,0.00001433377,0.000124863,0.001436223,0.9863302],"study_design_scores_gemma":[0.0005072539,0.000818025,0.001060125,0.00861452,0.0002664364,0.00002945056,0.000004721755,9.493842e-7,0.00002068933,0.00001731441,0.9884177,0.0002428186],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001902109,0.9764789,0.000002578392,6.707223e-7,0.0001566524,0.001093261,0.00005153103,0.00003811093,0.02027619],"genre_scores_gemma":[0.0003434351,0.9986876,0.00003155865,0.00001626008,0.0002532928,0.0001490707,0.00002079758,0.00008978196,0.000408179],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9869815,"threshold_uncertainty_score":0.9999607,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283169331","doi":"10.1007/s40268-022-00391-6","title":"Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch","year":2022,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Adverse effect; Edaravone; Amyotrophic lateral sclerosis; Postmarketing surveillance; Clinical trial; Disease; Intensive care medicine; Internal medicine","authors":[{"name":"Angela Genge","is_ca":true},{"name":"Benjamin Rix Brooks","is_ca":false},{"name":"Björn Oskarsson","is_ca":false},{"name":"Alexander Kalin","is_ca":false},{"name":"Ming Ji","is_ca":false},{"name":"Stephen Apple","is_ca":false},{"name":"Laura Bower","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03374131150750272,"gpt":0.3130737246580986,"spread":0.2793324131505959,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009292496,0.00008663112,0.0002931331,0.0000811748,0.0001200198,0.00001076751,0.0008948381,0.00003994565,0.001833807],"category_scores_gemma":[0.0001997368,0.00004720296,0.0001463403,0.0009622342,0.0001345387,0.0000392133,0.001061226,0.0003762274,0.000007933384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001256818,"about_ca_system_score_gemma":0.0001125716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001863285,"about_ca_topic_score_gemma":0.0003430312,"domain_scores_codex":[0.9983063,0.0002074223,0.0002842933,0.0003062452,0.0006683028,0.0002274709],"domain_scores_gemma":[0.9978632,0.0003701098,0.00007253588,0.001607295,0.00004183326,0.00004504184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002997479,0.0004737742,0.9456369,0.00004278885,0.002610825,0.00001074146,0.005016412,0.001104547,0.002074515,0.0004029872,0.03471693,0.00491206],"study_design_scores_gemma":[0.0009107537,0.00004317677,0.9392733,0.00001969253,0.0004714787,3.855957e-7,0.0003673829,0.007441174,0.00003518862,0.0001024051,0.05127342,0.00006166384],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864593,0.0003161927,0.00004086996,0.009442679,0.0001191333,0.0005966433,0.002277102,0.00001023244,0.0007378614],"genre_scores_gemma":[0.9972146,0.00005335837,0.000234778,0.0009196721,0.0001047748,0.00009651908,0.0004096297,0.00001497711,0.0009517167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01655649,"threshold_uncertainty_score":0.9990786,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386046570","doi":"10.1007/s40268-023-00428-4","title":"Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature","year":2023,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Oral and gingival health research","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Tacrolimus; Everolimus; Sirolimus; Medicine; Calcineurin; Dosing; Therapeutic drug monitoring; Adverse effect; Pharmacology; Internal medicine; Ciclosporin; Transplantation; Drug","authors":[{"name":"Aparna Wagle Shukla","is_ca":false},{"name":"Caroline Lunny","is_ca":false},{"name":"Omar Mahboob","is_ca":false},{"name":"Uzair Khalid","is_ca":true},{"name":"Malea Joyce","is_ca":true},{"name":"Nivedita Jha","is_ca":false},{"name":"Nandakumar Nagaraja","is_ca":false},{"name":"Ashutosh M. Shukla","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2153648129055369,"gpt":0.5519977062624285,"spread":0.3366328933568916,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003520955,0.0007321511,0.003572107,0.0004257224,0.0004274205,0.00001505573,0.001612868,0.001209248,0.0004818533],"category_scores_gemma":[0.001454267,0.000379076,0.000741559,0.005050178,0.00009779715,0.0001120674,0.0009096834,0.005348978,0.000751945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005571589,"about_ca_system_score_gemma":0.00300232,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004458979,"about_ca_topic_score_gemma":0.0001068351,"domain_scores_codex":[0.9904157,0.003320196,0.002878601,0.0008236174,0.001073279,0.001488594],"domain_scores_gemma":[0.9940175,0.002458355,0.00137107,0.001532878,0.0003015132,0.0003186802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003440311,0.00007752683,0.00003708542,0.6956304,0.00004629412,0.00001831153,0.0007707487,1.615063e-8,1.658348e-7,0.00006919121,0.06522775,0.2380882],"study_design_scores_gemma":[0.0002654489,0.00003924212,0.00004302577,0.4102716,0.00009085128,0.000003117984,0.00009104225,8.460192e-7,1.207769e-7,0.0000600172,0.5889235,0.0002111771],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001064464,0.9870061,6.05702e-8,0.001918061,0.001452688,0.006545556,0.0009826975,0.0001128145,0.001875572],"genre_scores_gemma":[0.00001002588,0.9723024,0.00001563255,0.001942976,0.0006770817,0.001325417,0.0003123375,0.0001790893,0.02323505],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5236957,"threshold_uncertainty_score":0.9998661,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2014795914","doi":"10.1007/s40268-013-0030-8","title":"An In Vitro Analysis of Disintegration Times of Different Formulations of Olanzapine Orodispersible Tablet: A Preliminary Report","year":2013,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Eli Lilly (Canada); Waypoint Centre for Mental Health Care; University of Toronto","funders":"Eli Lilly and Company","keywords":"Olanzapine; Active ingredient; Dissolution; Excipient; Chromatography; Dosage form; Dissolution testing; Materials science; Pharmacology; Chemistry; Medicine; Biopharmaceutics Classification System; Schizophrenia (object-oriented programming)","authors":[{"name":"D.T. Hobbs","is_ca":false},{"name":"Jamie Karagianis","is_ca":true},{"name":"Tamás Treuer","is_ca":false},{"name":"Joel Raskin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04067849629454533,"gpt":0.3935812172620812,"spread":0.3529027209675358,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003881452,0.0001336433,0.0005400434,0.0006443027,0.00002289155,0.000002677928,0.0001604943,0.0001501967,0.0006187253],"category_scores_gemma":[0.00007335554,0.0001188647,0.0001110232,0.0008443548,0.0001012293,0.0002389467,0.00003642129,0.0002018076,0.000003346383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007323801,"about_ca_system_score_gemma":0.00003558856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006548842,"about_ca_topic_score_gemma":0.0001664921,"domain_scores_codex":[0.9983321,0.0002368151,0.0008789567,0.0002153986,0.0001541745,0.0001825927],"domain_scores_gemma":[0.9987264,0.000277767,0.0004652646,0.0003125903,0.0001620108,0.00005596266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0007301555,0.001662781,0.4234281,0.0001673664,0.0005350019,0.00001023744,0.007048815,0.05969011,0.5008631,0.001145492,0.0001238852,0.004595011],"study_design_scores_gemma":[0.001526959,0.0002181325,0.2182906,0.00006555984,0.0005946422,0.000005153543,0.002410342,0.4657936,0.3098968,0.0008321028,0.0001398165,0.0002262389],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970161,0.0001886809,0.0009133587,0.0000634645,0.0001183773,0.0004759984,0.00008725067,0.00001119989,0.001125615],"genre_scores_gemma":[0.9987488,0.00003441953,0.0006352661,0.00001785543,0.00001536057,0.00005608351,0.0002876819,0.00001000998,0.0001945588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4061036,"threshold_uncertainty_score":0.6774607,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2802063352","doi":"10.1007/s40268-018-0232-1","title":"A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep Impairment","year":2018,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"GlaxoSmithKline","keywords":"Nasal administration; Cmax; Pharmacokinetics; Medicine; Pharmacodynamics; Pharmacology; Bioavailability; Nasal spray; Dosing; Area under the curve; Oral administration; Anesthesia","authors":[{"name":"Mark Allison","is_ca":true},{"name":"Cecilia Hale","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01161056248182597,"gpt":0.3292209934672916,"spread":0.3176104309854656,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003591246,0.0001552891,0.0003375493,0.0002704091,0.00002038997,0.000004738818,0.0001826934,0.00003535591,0.00004311987],"category_scores_gemma":[0.00002802638,0.0001029079,0.00003082757,0.0006175076,0.0004586939,0.00004529014,0.0001762813,0.000317713,6.289511e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002401491,"about_ca_system_score_gemma":0.00006382284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002091204,"about_ca_topic_score_gemma":0.0004820834,"domain_scores_codex":[0.99848,0.0001274164,0.0003991182,0.0002579654,0.0004561292,0.0002793744],"domain_scores_gemma":[0.9992986,0.00006770824,0.0001200407,0.0002980662,0.000143184,0.00007238489],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007840861,0.01929363,0.6817237,0.0009095261,0.0005534597,0.0001635539,0.03171733,0.0001895797,0.1393665,0.00005901041,0.0000204616,0.1181624],"study_design_scores_gemma":[0.1100708,0.02213415,0.5541448,0.0005274255,0.0003239322,0.00006633171,0.008673143,0.1208116,0.182858,0.00003002261,0.00004056036,0.0003191306],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978808,0.0001169513,0.00003752779,0.0001667066,0.0001122069,0.001509867,0.000009891949,0.000007061662,0.0001590268],"genre_scores_gemma":[0.9997129,0.00002999819,0.00008753888,0.00002491288,0.00006947471,0.00003778885,0.000002405888,0.0000217888,0.00001316825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1275789,"threshold_uncertainty_score":0.4196463,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2520135767","doi":"10.1007/s40268-016-0142-z","title":"Safety of Mebendazole Use During Lactation: A Case Series Report","year":2016,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Mebendazole; Breastfeeding; Medicine; Adverse effect; Lactation; Irritability; Pediatrics; Obstetrics; Pregnancy; Internal medicine; Anxiety; Psychiatry; Biology","authors":[{"name":"Nour Karra","is_ca":false},{"name":"Rana Cohen","is_ca":false},{"name":"Maya Berlin","is_ca":false},{"name":"Natalie Dinavitser","is_ca":false},{"name":"Gideon Koren","is_ca":true},{"name":"Matitiahu Berkovitch","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02102129683009323,"gpt":0.2973752522973009,"spread":0.2763539554672076,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002240305,0.00006173685,0.0001452674,0.00006400491,0.00002924616,0.000006950253,0.00002788766,0.00003933967,0.0001653339],"category_scores_gemma":[0.0003249437,0.00004054235,0.00003161119,0.0001118634,0.00006500553,0.0005788757,0.00002405945,0.00006182147,0.00000820986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003293988,"about_ca_system_score_gemma":0.00004578569,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000326325,"about_ca_topic_score_gemma":0.00005648392,"domain_scores_codex":[0.9993178,0.00001795802,0.000291385,0.0001293247,0.0001349979,0.0001085588],"domain_scores_gemma":[0.9994503,0.0001079976,0.0001464955,0.0001729441,0.0000775171,0.0000447192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002797144,0.0002866125,0.8783738,0.0004817484,0.0001465741,0.01641767,0.007625449,0.00001780466,0.03552412,0.002361681,0.0006031343,0.05536428],"study_design_scores_gemma":[0.002458509,0.0001128342,0.8941946,0.0007401058,0.00006384747,0.06639475,0.001609518,0.00001427446,0.01922198,0.0001032234,0.01491117,0.0001751801],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919955,0.00004812801,0.00000912102,0.004692632,0.0001337107,0.00008408308,0.000007339521,0.00002181754,0.003007658],"genre_scores_gemma":[0.9966796,0.00007802403,0.000749554,0.00003626917,0.00008056786,0.000005016158,0.00000180029,0.000007057019,0.002362103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0551891,"threshold_uncertainty_score":0.181029,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1983697728","doi":"10.2165/11596340-000000000-00000","title":"Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Darunavir; Raltegravir; Ritonavir; Medicine; Maraviroc; Viral load; Regimen; Adverse effect; Internal medicine; Integrase inhibitor; Clinical endpoint; Gastroenterology; Virology; Pharmacology; Randomized controlled trial; Human immunodeficiency virus (HIV); Antiretroviral therapy","authors":[{"name":"Mabrouk Elgadi","is_ca":true},{"name":"Peter J. Piliero","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04272275973899473,"gpt":0.290875164831624,"spread":0.2481524050926293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007170171,0.000204715,0.0003047742,0.000191188,0.00003930422,0.000006570263,0.00008204192,0.00008704461,0.0005471301],"category_scores_gemma":[0.00002813925,0.0001706533,0.00005972593,0.0002955191,0.00005849835,0.00009816742,0.00003074199,0.00009648638,0.0003898131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003846205,"about_ca_system_score_gemma":0.00009340543,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004825919,"about_ca_topic_score_gemma":0.0003933756,"domain_scores_codex":[0.9988166,0.00003414377,0.0002787435,0.00032408,0.0002064484,0.0003399873],"domain_scores_gemma":[0.9995031,0.00003794356,0.00004915057,0.0002660031,0.00002903402,0.0001147164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001604628,0.002191548,0.8901406,0.00001205255,0.00007668872,0.0002001249,0.06632894,5.139723e-7,0.0000351503,0.00008339802,0.0003005394,0.03902584],"study_design_scores_gemma":[0.04620121,0.001167443,0.9321352,0.0002146418,0.00009190747,0.000003759215,0.006488275,0.00009906124,0.003867631,0.0001330713,0.009116902,0.0004809037],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9508016,0.00009568496,0.000001416363,0.0001357241,0.0002294894,0.000538482,0.000004283546,0.00004695158,0.04814638],"genre_scores_gemma":[0.9946605,0.00006523075,0.001105882,0.000049348,0.00001737751,0.0001090654,0.0001188051,0.00002144596,0.003852361],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05984066,"threshold_uncertainty_score":0.6959038,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4410829664","doi":"10.1007/s40268-025-00511-y","title":"Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema","year":2025,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"CSL Behring","keywords":"Hereditary angioedema; Medicine; Prophylactic treatment; Term (time); Intensive care medicine; Angioedema; Meta-analysis; Dermatology; Internal medicine","authors":[{"name":"Sarah N. Walsh","is_ca":true},{"name":"Meaghan Bartlett","is_ca":true},{"name":"Elizabeth M. Salvo‐Halloran","is_ca":true},{"name":"John Sears","is_ca":false},{"name":"Yinglei Li","is_ca":false},{"name":"Maebh Kelly","is_ca":false},{"name":"S. Gavata-Steiger","is_ca":false},{"name":"Chiara Nenci","is_ca":false},{"name":"Iris Jacobs","is_ca":false},{"name":"Ingo Pragst","is_ca":false},{"name":"Neelanjana Ray","is_ca":false},{"name":"Imtiaz A. Samjoo","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0998001851149383,"gpt":0.3768648895175485,"spread":0.2770647044026102,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002037397,0.000488875,0.005498479,0.0004933176,0.00003988884,0.000007439799,0.0001511267,0.0002274079,0.0002876661],"category_scores_gemma":[0.00002739853,0.0002739731,0.00280772,0.001260622,0.00012007,0.00004356354,0.00003033551,0.00008991505,8.897551e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001297199,"about_ca_system_score_gemma":0.0002762935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003054849,"about_ca_topic_score_gemma":0.00002300173,"domain_scores_codex":[0.9976674,0.0001695943,0.001055093,0.0004759933,0.0003313695,0.0003005707],"domain_scores_gemma":[0.9977184,0.0008707856,0.0007441294,0.0004019779,0.0001930588,0.00007164258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000811214,0.003137431,0.04708545,0.01973374,0.4159431,0.00002568854,0.0006151837,0.0001141001,8.153059e-8,0.0000819042,0.0002308181,0.5122213],"study_design_scores_gemma":[0.002311587,0.001530545,0.02470949,0.001407242,0.9544173,0.000001479858,0.00002219386,0.00002743277,0.000005307954,0.00003768921,0.01517935,0.0003503888],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002671984,0.9935542,0.00004009546,0.00004153189,0.0001395137,0.003172931,0.0002860749,0.00002037484,0.00007324715],"genre_scores_gemma":[0.01937955,0.9757503,0.0006675262,0.00006072119,0.0002013857,0.001028909,0.001933162,0.00004934957,0.0009290468],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5384742,"threshold_uncertainty_score":0.9999713,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2530554915","doi":"10.1007/s40268-016-0145-9","title":"Bioequivalence and Pharmacokinetic Evaluation Study of Acetaminophen vs. Acetaminophen Plus Caffeine Tablets in Healthy Mexican Volunteers","year":2016,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Fraser Health","funders":"","keywords":"Bioequivalence; Acetaminophen; Medicine; Pharmacokinetics; Caffeine; Pharmacology; Immediate release; Internal medicine","authors":[{"name":"Nora Guzmán","is_ca":true},{"name":"Daniel Ruiz‐Molina","is_ca":false},{"name":"Benigno Figueroa Núñez","is_ca":false},{"name":"Juan Carlos Soto-Sosa","is_ca":false},{"name":"Jorge Eduardo Herrera Abarca","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1256013498076976,"gpt":0.4379432897756987,"spread":0.3123419399680011,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003154419,0.0002884105,0.0005003054,0.0004667997,0.0001199923,0.00001083724,0.00029098,0.0002918055,0.0004124828],"category_scores_gemma":[0.0002069013,0.0002481218,0.00004278201,0.0005939016,0.0002277056,0.0002596936,0.0001401752,0.000622413,0.00003089696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004866483,"about_ca_system_score_gemma":0.000182798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001164803,"about_ca_topic_score_gemma":0.0008557139,"domain_scores_codex":[0.9961994,0.00153922,0.0007086965,0.0005745472,0.0004176761,0.0005604352],"domain_scores_gemma":[0.9987181,0.0004702098,0.0002414206,0.0002704024,0.0001227905,0.0001770377],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007195813,0.003963041,0.3653368,0.0006146447,0.0002802141,0.00005754469,0.0396994,0.00477944,0.2592514,0.0002891295,0.000395213,0.3181373],"study_design_scores_gemma":[0.09483739,0.006104716,0.6305457,0.000653883,0.0008691114,0.00005350798,0.009892108,0.09041473,0.156251,0.001913648,0.006296586,0.00216769],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943421,0.0004983048,0.00002954454,0.001108842,0.0008628772,0.002262641,0.00003468676,0.00004336402,0.0008175841],"genre_scores_gemma":[0.9984056,0.0004781155,0.00004587819,0.0003851437,0.0001037535,0.0003693397,0.000006545032,0.00002570941,0.0001799615],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3159696,"threshold_uncertainty_score":0.9999971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3092259600","doi":"10.1007/s40268-020-00323-2","title":"Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling","year":2020,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of Alberta","funders":"National Research Foundation of Korea","keywords":"Pharmacokinetics; Phenytoin; Pharmacology; Medicine; Chemistry; Epilepsy","authors":[{"name":"Heajin Jun","is_ca":true},{"name":"Yan Rong","is_ca":true},{"name":"Catharina Yih","is_ca":true},{"name":"Jordan Ho","is_ca":true},{"name":"Wendy Cheng","is_ca":true},{"name":"Tony K. L. Kiang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07519172777881467,"gpt":0.3256941495750178,"spread":0.2505024217962031,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002706046,0.0001960931,0.0006282855,0.000106082,0.00005758395,0.000006523239,0.0001536489,0.00007025582,0.000003502535],"category_scores_gemma":[0.0002287046,0.0001423033,0.00009195205,0.0004268431,0.00008998551,0.00009031683,0.0001693045,0.0004150212,0.000001161919],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006746554,"about_ca_system_score_gemma":0.00003810289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000955128,"about_ca_topic_score_gemma":0.000003213848,"domain_scores_codex":[0.9984416,0.0001204194,0.0005663343,0.0002484119,0.0003212454,0.0003020123],"domain_scores_gemma":[0.9992697,0.0001843434,0.0002143436,0.0001175411,0.0001311703,0.00008289835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001136994,0.001348011,0.04419997,0.002470943,0.0002294783,0.00004155543,0.01059751,0.1586606,0.7792339,0.0002126806,0.00005085026,0.001817557],"study_design_scores_gemma":[0.003381225,0.0002030917,0.002064985,0.0007045214,0.00007742435,5.329673e-7,0.0003575631,0.911267,0.08177931,0.00003402428,0.000006842168,0.0001234273],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945946,0.00007119053,0.003214644,0.0004962612,0.0001005289,0.001362405,0.00001738568,0.00001310222,0.0001299056],"genre_scores_gemma":[0.9976611,0.00004194356,0.001690907,0.0004622261,0.00007627452,0.00003711419,0.00000728131,0.00002105575,0.000002135474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7526065,"threshold_uncertainty_score":0.5802961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399384704","doi":"10.1007/s40268-024-00462-w","title":"Safety and Efficacy of Lemborexant in Insomnia Patients: Results of a Postmarketing Observational Study of Dayvigo® Tablets","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Sleep and related disorders","field":"Psychology","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Somnolence; Postmarketing surveillance; Insomnia; Sleep paralysis; Medicine; Observational study; Suicidal ideation; Adverse effect; Sleep disorder; Psychiatry; Internal medicine; Poison control; Emergency medicine; Injury prevention; Excessive daytime sleepiness","authors":[{"name":"Kazuo Mishima","is_ca":false},{"name":"Kenichi Fujimoto","is_ca":false},{"name":"Akira Endo","is_ca":false},{"name":"Mika Ishii","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02254376746278476,"gpt":0.3118689907720825,"spread":0.2893252233092978,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000666637,0.00009225485,0.0002422782,0.0002731736,0.00001143894,0.000003206912,0.0001004007,0.00009828365,0.00003931217],"category_scores_gemma":[0.0002787824,0.00008203436,0.00002710008,0.0005903726,0.00006394781,0.00004995329,0.00005558199,0.0001827604,0.000001797654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002022539,"about_ca_system_score_gemma":0.00003040245,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001173254,"about_ca_topic_score_gemma":0.0001078881,"domain_scores_codex":[0.998491,0.0001853867,0.0007608802,0.0002440935,0.0001823346,0.0001363076],"domain_scores_gemma":[0.9989107,0.0006909727,0.0001441226,0.0001770775,0.00005805271,0.00001904308],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003666689,0.00579874,0.8689668,0.0001608661,0.0003560494,0.00001370128,0.09046546,0.0005947625,0.0001599832,0.001682514,0.0004985344,0.0276359],"study_design_scores_gemma":[0.009635021,0.000294039,0.9820795,0.00030291,0.00003137159,3.664586e-7,0.006839731,0.000328401,0.00001958676,0.00008188263,0.0003047064,0.00008248461],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912505,0.0007140082,0.00000158836,0.00008264364,0.0002536404,0.0003777335,0.00005827106,0.000009054161,0.007252604],"genre_scores_gemma":[0.9997745,0.00004898936,0.00004059519,0.00001485129,0.000007378606,0.000007083919,0.00003781602,0.00001123121,0.00005758677],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1131127,"threshold_uncertainty_score":0.3345264,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2749649169","doi":"10.1007/s40268-017-0201-0","title":"Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial","year":2017,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Body Composition Measurement Techniques","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"AbbVie","keywords":"Medicine; Placebo; Urology; Internal medicine; Diabetes mellitus; Population; Diabetic nephropathy; Adverse effect; Anesthesia; Endocrinology; Pathology","authors":[{"name":"David J. Webb","is_ca":false},{"name":"Blai Coll","is_ca":false},{"name":"Hiddo J.L. Heerspink","is_ca":false},{"name":"Dennis L. Andress","is_ca":false},{"name":"Yili Pritchett","is_ca":false},{"name":"John J. Brennan","is_ca":false},{"name":"Mark T. Houser","is_ca":false},{"name":"Ricardo Correa‐Rotter","is_ca":false},{"name":"Donald E. Kohan","is_ca":false},{"name":"Hirofumi Makino","is_ca":false},{"name":"Vlado Perkovic","is_ca":false},{"name":"Giuseppe Remuzzi","is_ca":false},{"name":"Sheldon W. Tobe","is_ca":true},{"name":"Robert Toto","is_ca":false},{"name":"Robert S. Busch","is_ca":false},{"name":"Pablo E. Pérgola","is_ca":false},{"name":"Hans‐Henrik Parving","is_ca":false},{"name":"Dick de Zeeuw","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03188235948794835,"gpt":0.3793242938575151,"spread":0.3474419343695667,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00485713,0.0002173473,0.001415842,0.0002490373,0.0000737349,0.00002438791,0.0003487966,0.0001076921,0.00002075062],"category_scores_gemma":[0.0005099556,0.0001339985,0.0003753036,0.000153721,0.0003160981,0.00007522182,0.00007716628,0.0003733416,0.000001586541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001714681,"about_ca_system_score_gemma":0.0001262859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001096697,"about_ca_topic_score_gemma":0.00003285889,"domain_scores_codex":[0.9971705,0.0008516351,0.0007954465,0.0002769875,0.0006859646,0.0002194496],"domain_scores_gemma":[0.9975371,0.0007770037,0.0007010661,0.0008678561,0.00007141072,0.00004557684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9286799,0.0003411976,0.06505194,0.0001555946,0.00008579188,0.000008447617,0.00008553673,0.00002104948,0.00476461,0.0002262584,0.0000175722,0.0005620353],"study_design_scores_gemma":[0.9119965,0.0009368582,0.01463246,0.001115862,0.000258585,0.000001866155,0.00001251956,0.0008470573,0.07001897,0.00007712308,0.000001859037,0.0001003142],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852026,0.00007451916,0.00009738551,0.0004812598,0.0003289767,0.0100632,0.0000032187,0.00002614773,0.003722707],"genre_scores_gemma":[0.9984375,0.00002161768,0.0003065647,0.00002581152,0.00009492177,0.001055565,0.000003651174,0.00001874218,0.00003564302],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06525436,"threshold_uncertainty_score":0.5464301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2620644176","doi":"10.1007/s40268-017-0186-8","title":"Comparison of Generic Drug Reviews for Marketing Authorization between Japan and Canada","year":2017,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Canada","funders":"","keywords":"Marketing authorization; Authorization; Drug; Business; Prior authorization; Medicine; Pharmacology; Computer science; Computer security","authors":[{"name":"Ryosuke Kuribayashi","is_ca":true},{"name":"Scott Appleton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.259178522825063,"gpt":0.5329395756676412,"spread":0.2737610528425781,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002888141,0.0001051784,0.0003407681,0.0000358076,0.0003099674,0.000013849,0.0002458022,0.00008976246,0.00008616065],"category_scores_gemma":[0.001701387,0.0000990205,0.00002913892,0.00003612625,0.0001250558,0.0001404869,0.00007315363,0.0003713515,0.000001540205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004014571,"about_ca_system_score_gemma":0.0001269126,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01898591,"about_ca_topic_score_gemma":0.0262075,"domain_scores_codex":[0.9986183,0.0004609629,0.0004224608,0.0001800534,0.0000993635,0.0002188703],"domain_scores_gemma":[0.9978703,0.001323111,0.0004942086,0.0001456282,0.0000340687,0.000132706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001690719,0.0000772135,0.7588764,0.0004727978,0.00004522887,0.00000123639,0.001151403,0.00002041831,0.001429751,0.0001910444,0.03449204,0.2030734],"study_design_scores_gemma":[0.001325852,0.00002008822,0.08866505,0.00007887987,0.0001531553,7.352457e-7,0.0003233183,0.005399799,0.009307411,0.0001167071,0.8944414,0.0001676212],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901486,0.002600977,0.000104123,0.002481804,0.0009546948,0.0005065621,0.00004668237,0.000008914082,0.003147625],"genre_scores_gemma":[0.9976073,0.0008797614,0.000371757,0.0004626771,0.0002367919,0.00003976107,0.00002364358,0.000008408042,0.0003699117],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8599494,"threshold_uncertainty_score":0.9915617,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015373259","doi":"10.1007/s40268-014-0057-5","title":"Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study","year":2014,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Hyperintensity; Medicine; Concomitant; Internal medicine; Cognitive decline; Confounding; Montreal Cognitive Assessment; Stroke (engine); Disease; Retrospective cohort study; Cognition; Pediatrics; Magnetic resonance imaging; Psychiatry; Dementia","authors":[{"name":"Kok Pin Ng","is_ca":false},{"name":"Aloysius Ng","is_ca":false},{"name":"Pryseley Nkouibert Assam","is_ca":false},{"name":"Esther Heng","is_ca":false},{"name":"Nagaendran Kandiah","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01276670842920622,"gpt":0.3080751794419951,"spread":0.2953084710127889,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002482653,0.0002242944,0.0003887527,0.0002213079,0.0000319838,0.00003047943,0.0001338251,0.00003866916,0.001293419],"category_scores_gemma":[0.00007405988,0.0001670009,0.00006623638,0.0002618064,0.0001624734,0.0001228684,0.00006965293,0.000278431,0.00005450111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005154826,"about_ca_system_score_gemma":0.0001177653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001688285,"about_ca_topic_score_gemma":0.0001290722,"domain_scores_codex":[0.9980866,0.000216874,0.0003153142,0.0004439791,0.0005648283,0.0003723933],"domain_scores_gemma":[0.9990425,0.0002491692,0.00007548252,0.0002445882,0.0001392531,0.000249016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005666241,0.001431121,0.986995,0.00003200535,0.0002004586,0.0001181188,0.002508225,5.35279e-7,0.0001706175,0.000007021212,0.00003614595,0.002834476],"study_design_scores_gemma":[0.009398734,0.0006484078,0.986415,0.0008140583,0.0002464043,7.202443e-7,0.001324644,0.0001055348,0.0007019539,0.0001438152,0.000005068478,0.0001957127],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962376,0.0009872452,0.00001815822,0.0003051014,0.00003681359,0.001603069,0.00008409303,0.0000157314,0.0007121757],"genre_scores_gemma":[0.9988199,0.00002722503,0.00001625818,0.0004452404,0.00005250208,0.0002651351,0.0001660213,0.00003153735,0.0001762013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003732493,"threshold_uncertainty_score":0.9996195,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4232278611","doi":"10.1007/bf03259727","title":"Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users","year":2011,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Celerion (Canada)","funders":"Shionogi; Astellas Pharma; Purdue University; Eisai; Bayer HealthCare; Boston Scientific Corporation; Purdue Pharma; Gilead Sciences; GlaxoSmithKline; Nevro; Teva Pharmaceutical Industries; AstraZeneca; Pfizer","keywords":"Euphoriant; Naltrexone; Morphine; Medicine; Heroin; Anesthesia; Opioid; Narcotic antagonist; Visual analogue scale; Pharmacology; Drug; Internal medicine; Psychiatry","authors":[{"name":"Lynn R. Webster","is_ca":false},{"name":"Franklin K. Johnson","is_ca":false},{"name":"Joseph Stauffer","is_ca":false},{"name":"Beatrice Setnik","is_ca":false},{"name":"Sabrina Ciric","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0124207090589173,"gpt":0.2684139299841857,"spread":0.2559932209252684,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002231793,0.0003848311,0.0007180068,0.0005730577,0.00003765472,0.00001230846,0.0001743458,0.0001494379,0.0001559254],"category_scores_gemma":[0.00007768692,0.0003244825,0.0001136441,0.0004730875,0.00008949805,0.00009912463,0.00007929846,0.0003847095,0.00002409319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005058937,"about_ca_system_score_gemma":0.0001972482,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01069556,"about_ca_topic_score_gemma":0.0002278123,"domain_scores_codex":[0.9979134,0.0000945924,0.0005000094,0.0005448883,0.0004034341,0.0005436448],"domain_scores_gemma":[0.9989283,0.0001242067,0.0001655014,0.000522072,0.00004928935,0.000210636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002773086,0.009903467,0.6413534,0.0008197724,0.0003791444,0.002157336,0.2890044,0.00008310922,0.02094052,0.000642423,0.0001057847,0.03183751],"study_design_scores_gemma":[0.006682643,0.003411312,0.9467455,0.0006546377,0.00007420383,0.0000942401,0.004186672,0.0001268874,0.03733695,0.0003262626,0.000004511252,0.0003561756],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968446,0.000475852,0.000006498776,0.00004217097,0.0002527583,0.001144436,0.000009789041,0.00003767024,0.001186202],"genre_scores_gemma":[0.998722,0.0002548173,0.0006060619,0.00006198016,0.00004553242,0.0001490096,0.00001999325,0.00005329014,0.00008729783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3053921,"threshold_uncertainty_score":0.9999207,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002722147","doi":"10.2165/00126839-200607010-00003","title":"A Newly Synthesised Molybdenum/Ascorbic Acid Complex Alleviates Some Effects of Cardiomyopathy in Streptozocin-Induced Diabetic Rats","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Vanadium and Halogenation Chemistry","field":"Chemistry","cited_by":6,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Allison University","funders":"","keywords":"Ascorbic acid; Streptozocin; Internal medicine; Diabetes mellitus; Endocrinology; Diabetic cardiomyopathy; Medicine; Insulin; Chemistry; Streptozotocin; Heart failure; Cardiomyopathy; Food science","authors":[{"name":"K. MacDonald","is_ca":true},{"name":"J. Bailey","is_ca":true},{"name":"C MacRory","is_ca":true},{"name":"Christian Friis","is_ca":true},{"name":"Christopher M. Vogels","is_ca":true},{"name":"Thomas L. Broderick","is_ca":false},{"name":"Stephen A. Westcott","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008430378460796025,"gpt":0.2201597351369941,"spread":0.2117293566761981,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001781468,0.0002833491,0.000561181,0.0001711944,0.00003995764,0.00002610291,0.0003473661,0.0002219573,0.0001945851],"category_scores_gemma":[0.0001550704,0.0003105568,0.0001619195,0.0002799428,0.00007208209,0.0001004854,0.00007158852,0.000250706,0.00002196967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001964282,"about_ca_system_score_gemma":0.00009817859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006696076,"about_ca_topic_score_gemma":0.0001309081,"domain_scores_codex":[0.9981669,0.00005663956,0.0005643655,0.0004304399,0.0003299479,0.0004517258],"domain_scores_gemma":[0.9988894,0.0003302098,0.0001877251,0.0004545056,0.00005015544,0.00008793781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00002010877,0.0001996425,0.01788397,0.0006942807,0.00002661346,0.00005442434,0.0004129588,0.0001505502,0.9794329,0.0001125292,0.0001733391,0.0008386637],"study_design_scores_gemma":[0.001551475,0.00001067417,0.01729969,0.0002676745,0.00002662022,0.000003026342,0.0002779824,0.0002666357,0.9791626,0.0007714511,0.00005978591,0.0003024344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992626,0.0006997443,0.000002935327,0.0001030144,0.00007490782,0.0001405881,0.00002418824,0.00005669418,0.006271982],"genre_scores_gemma":[0.9993088,0.0000224472,0.00008702176,0.00004441363,0.0001541035,0.00007233045,0.00006508907,0.00003887806,0.0002069308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00668284,"threshold_uncertainty_score":0.9999347,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990684646","doi":"10.2165/00126839-200506010-00005","title":"Pharmacokinetics and Pilot Efficacy of???a Mesalazine Rectal Gel in Distal Ulcerative Colitis","year":2005,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada); University of Alberta; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Ulcerative colitis; Mesalazine; Medicine; Pharmacokinetics; Gastroenterology; Internal medicine; Pharmacotherapy; Disease","authors":[{"name":"Guy Aumais","is_ca":true},{"name":"Marc Lefebvre","is_ca":true},{"name":"Julie Massicotte","is_ca":true},{"name":"Claude Tremblay","is_ca":true},{"name":"Joelle Kasbo","is_ca":true},{"name":"Jean-S bastien Brunet","is_ca":true},{"name":"Cynthia Cardinal","is_ca":true},{"name":"Michael Grace","is_ca":true},{"name":"Jean Sp nard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007117704362962512,"gpt":0.2642461372299111,"spread":0.2571284328669486,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001408595,0.0001163775,0.0001188741,0.00005537443,0.00001569467,0.000007745517,0.00008660195,0.00005399905,0.00002710464],"category_scores_gemma":[0.00006917252,0.0001249657,0.00002761944,0.0000684827,0.000109356,0.000004751711,0.00008018748,0.00008466619,0.000004279512],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002387171,"about_ca_system_score_gemma":0.0000498554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001578159,"about_ca_topic_score_gemma":0.0002676625,"domain_scores_codex":[0.9992083,0.00007598483,0.0002282162,0.0002215661,0.00008479501,0.0001811823],"domain_scores_gemma":[0.9996935,0.00001963502,0.00005052403,0.0001400661,0.00003150255,0.00006483807],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01205205,0.002708057,0.1963502,0.0003415952,0.0001788199,0.000362329,0.005144049,0.002303489,0.7248417,0.002545958,0.004198003,0.04897387],"study_design_scores_gemma":[0.004899764,0.0001755872,0.9040204,0.00003861876,0.00001454887,0.000007475147,0.0001095803,0.000607711,0.08614617,0.00006012064,0.003646115,0.0002739364],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971101,0.0001727047,0.00001860055,0.0000798924,0.00004984892,0.0002076873,0.00004952656,0.000005466045,0.002306132],"genre_scores_gemma":[0.9991473,0.0001109849,0.0002585831,0.00009355832,0.0001246299,0.00001832584,0.00005681546,0.00001537261,0.0001744306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7076702,"threshold_uncertainty_score":0.5095953,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079921819","doi":"10.2165/00126839-200607020-00006","title":"Effect of a Novel Molybdenum Ascorbate Complex on Ex Vivo Myocardial Performance in Chemical??Diabetes Mellitus","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Vanadium and Halogenation Chemistry","field":"Chemistry","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Allison University","funders":"","keywords":"Diabetes mellitus; Medicine; Internal medicine; Streptozotocin; Endocrinology; Cardiac function curve; Insulin; Heart failure; Cardiology","authors":[{"name":"Tom L. Broderick","is_ca":false},{"name":"John R. Bailey","is_ca":true},{"name":"Karen J Gagnon","is_ca":true},{"name":"Sarah J. Lord","is_ca":true},{"name":"Christopher M. Vogels","is_ca":true},{"name":"Stephen A. Westcott","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007668220954864185,"gpt":0.2299303332794818,"spread":0.2222621123246176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002417315,0.0002105859,0.0003605564,0.00008838555,0.00002117566,0.00001321666,0.0002388289,0.000173209,0.0002292725],"category_scores_gemma":[0.0000488327,0.0002126681,0.0001006383,0.0002019664,0.0000848842,0.00004975386,0.0000462618,0.0002515276,0.0000177504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001452881,"about_ca_system_score_gemma":0.00003103397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001129565,"about_ca_topic_score_gemma":0.000009358732,"domain_scores_codex":[0.9986802,0.00001697628,0.0003872744,0.0003017953,0.0002645068,0.0003492491],"domain_scores_gemma":[0.9993058,0.000212106,0.0001119058,0.0002919095,0.00002812696,0.00005009712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00008758631,0.0002099941,0.02802152,0.0005355692,0.00001478942,0.000003577243,0.0001122871,0.0007834705,0.9679264,0.00008657172,0.0003003562,0.001917826],"study_design_scores_gemma":[0.002030897,0.00002502371,0.002331824,0.0001526646,0.0000100795,0.000001419838,0.00001856508,0.002782292,0.9913395,0.00002695456,0.001074526,0.0002062449],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9428698,0.0001154989,0.000001248979,0.0000401675,0.00004950423,0.00006946085,0.00005255805,0.00003069605,0.05677107],"genre_scores_gemma":[0.9993082,0.00001645172,0.00005667666,0.00003738354,0.0001575848,0.00003049258,0.00008632852,0.00002346471,0.0002834143],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05648766,"threshold_uncertainty_score":0.8672355,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3200529384","doi":"10.1007/s40268-021-00361-4","title":"The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process","year":2021,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Dalhousie University; University of Toronto; University Health Network; University of British Columbia; Alberta Children's Hospital; Queen Elizabeth II Health Sciences Centre; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; University of Calgary","funders":"Killam Trusts","keywords":"Enzyme replacement therapy; Fabry disease; Medicine; Adverse effect; Internal medicine; Disease","authors":[{"name":"Sandra Sirrs","is_ca":true},{"name":"Daniel G. Bichet","is_ca":true},{"name":"Chantal F. Morel","is_ca":true},{"name":"Adina Tocoian","is_ca":false},{"name":"Lan Lan","is_ca":false},{"name":"Michael L. West","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01011952908031251,"gpt":0.3144048204190735,"spread":0.304285291338761,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003228154,0.0000907139,0.0001817631,0.0001401183,0.00004224729,0.000008347096,0.00008853473,0.00002708702,0.00007972792],"category_scores_gemma":[0.0001528909,0.00006286757,0.0000462805,0.0004992187,0.0000431109,0.00006573132,0.00002039031,0.0001037493,6.981963e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002984541,"about_ca_system_score_gemma":0.001307159,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0684661,"about_ca_topic_score_gemma":0.1641692,"domain_scores_codex":[0.9986369,0.0000830656,0.0003184151,0.0001895521,0.000479506,0.0002925619],"domain_scores_gemma":[0.999264,0.00007162942,0.00007784001,0.000253751,0.0001721946,0.0001605538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009816238,0.0002186661,0.9833261,0.00008339286,0.0000467141,0.00003760104,0.003185916,0.000007009912,0.0001689239,0.00002388858,0.00002913266,0.01189106],"study_design_scores_gemma":[0.006579298,0.0002042607,0.9807189,0.0002045117,0.00001402551,2.755819e-7,0.00665084,0.00005684884,0.005056407,0.00003270349,0.0003988072,0.00008309261],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977689,0.0004714207,0.000003394227,0.0006836796,0.00002873268,0.000779234,0.00004935147,0.000003172826,0.0002120859],"genre_scores_gemma":[0.999544,0.00007762979,0.00002086177,0.00008848205,0.000006707294,0.00006887483,0.0001432729,0.00001397743,0.00003614274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09570307,"threshold_uncertainty_score":0.937737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402785536","doi":"10.1007/s40268-024-00491-5","title":"Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid Leukemia","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"National Institute of General Medical Sciences; National Cancer Institute; University of Pennsylvania; U.S. Department of Veterans Affairs","keywords":"Myeloid leukemia; Myeloid; Sensitivity (control systems); Trametinib; Myeloid cells; Medicine; Cancer research; Internal medicine; Biology; Genetics; Engineering; Signal transduction; MAPK/ERK pathway","authors":[{"name":"Mathieu Quesnel-Vallières","is_ca":true},{"name":"D. Schultz","is_ca":false},{"name":"Alena Orlenko","is_ca":false},{"name":"Yancy Lo","is_ca":false},{"name":"Jason H. Moore","is_ca":false},{"name":"Marylyn D. Ritchie","is_ca":false},{"name":"David A. Roth","is_ca":false},{"name":"Martin Carroll","is_ca":false},{"name":"Yoseph Barash","is_ca":false},{"name":"Kristen W. Lynch","is_ca":false},{"name":"Sara Cherry","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0125919187849387,"gpt":0.290093191493942,"spread":0.2775012727090033,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001018256,0.0003335439,0.0005680621,0.0006498137,0.00005111045,0.00009430131,0.0001474331,0.0003256958,0.0004298715],"category_scores_gemma":[0.0002559666,0.0003045956,0.0001532383,0.001309896,0.0001213747,0.0002253718,0.0001393093,0.001235999,0.0004843356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002204922,"about_ca_system_score_gemma":0.00078107,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007632794,"about_ca_topic_score_gemma":0.0001096019,"domain_scores_codex":[0.9970153,0.0002441456,0.0005476834,0.0007926584,0.0006647723,0.0007354541],"domain_scores_gemma":[0.9987121,0.0004789417,0.00005779378,0.000482551,0.00007704554,0.0001915248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002131296,0.00126836,0.05799663,0.002339022,0.0007518085,0.003395082,0.02365625,0.00004617602,0.509776,0.001533587,0.2082746,0.1888312],"study_design_scores_gemma":[0.01717097,0.0009062024,0.3283083,0.003097768,0.0005171284,0.0006203281,0.002967478,0.2806592,0.3220878,0.001811989,0.03962122,0.002231669],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884703,0.0005745069,0.0002971517,0.004617043,0.0002501396,0.0009819992,0.0001819466,0.0002139539,0.004413008],"genre_scores_gemma":[0.9909743,0.0003768566,0.001284388,0.0006892421,0.0001501823,0.0001755028,0.0004386508,0.00008325798,0.005827604],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.280613,"threshold_uncertainty_score":0.9999406,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3020645024","doi":"10.1007/s40268-020-00307-2","title":"Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers","year":2020,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval; Institut National de Santé Publique du Québec","funders":"Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Institut National de Santé Publique du Québec","keywords":"Angiotensin Receptor Blockers; Pharmacology; Brand names; Business; Chemistry; Medicine; Internal medicine; Renin–angiotensin system; Advertising","authors":[{"name":"Jacinthe Leclerc","is_ca":true},{"name":"Claudia Blais","is_ca":true},{"name":"Louis Rochette","is_ca":true},{"name":"Denis Hamel","is_ca":true},{"name":"Line Guénette","is_ca":true},{"name":"Claudia Beaudoin","is_ca":true},{"name":"Paul Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1037359045488901,"gpt":0.287392709109388,"spread":0.1836568045604979,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003554171,0.0002382691,0.0006778294,0.000223334,0.00009550765,0.0001157809,0.0003150529,0.0001023301,0.001014713],"category_scores_gemma":[0.0001145149,0.0002671138,0.0001709161,0.0003176852,0.00002595879,0.0001738851,0.0002400208,0.000278353,0.001317759],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002405979,"about_ca_system_score_gemma":0.00004593614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006843164,"about_ca_topic_score_gemma":0.00007909807,"domain_scores_codex":[0.9979302,0.00003062299,0.0007789919,0.0005995353,0.00004048449,0.0006201536],"domain_scores_gemma":[0.9988492,0.00007031884,0.0001813598,0.0002946205,0.000009403755,0.0005951038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001778145,0.0004100111,0.844846,0.00005783127,0.0003037935,0.00001137884,0.03588159,0.0002083128,0.0001572698,0.02357133,0.0714888,0.02288592],"study_design_scores_gemma":[0.001504822,0.00007905866,0.1403039,0.00001588082,0.00000384988,4.62239e-7,0.0001039872,0.005537824,0.00006832211,0.003867316,0.8479,0.0006145685],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7528427,0.000817324,0.0002613504,0.2440812,0.000426913,0.0002148356,0.0004805838,0.00004175626,0.0008333191],"genre_scores_gemma":[0.9075686,0.0001861118,0.002011458,0.08967514,0.0002993435,0.00003378444,0.00003584942,0.00004418972,0.0001455027],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7764112,"threshold_uncertainty_score":0.9999781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160030763","doi":"10.1007/s40268-014-0044-x","title":"Bioequivalence Study of Two Formulations of Ibandronic Acid 150-mg Film-Coated Tablets in Healthy Volunteers Under Fasting Conditions: A Randomized, Open-Label, Three-Way, Reference-Replicated Crossover Study","year":2014,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Bioequivalence; Crossover study; Confidence interval; Pharmacokinetics; Chromatography; Dosing; Bioavailability; Medicine; Chemistry; Pharmacology; Internal medicine","authors":[{"name":"Augusto Filipe","is_ca":false},{"name":"Pedro Pedroso","is_ca":false},{"name":"Susana Almeida","is_ca":false},{"name":"Rita Neves","is_ca":false},{"name":"Sylvie Boudreault","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06410950267279548,"gpt":0.3873579237050685,"spread":0.323248421032273,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002313091,0.000234328,0.001170775,0.0005049625,0.0001505757,0.00005023278,0.0003974386,0.00007705602,0.0001970933],"category_scores_gemma":[0.0008467753,0.0002014166,0.0000501583,0.000965695,0.000327491,0.0003263847,0.0002378618,0.0004146407,0.00001302687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001261996,"about_ca_system_score_gemma":0.0002471972,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01221604,"about_ca_topic_score_gemma":0.009822089,"domain_scores_codex":[0.9966198,0.0005647573,0.001239032,0.0004846244,0.0005778315,0.000514015],"domain_scores_gemma":[0.9978233,0.0007290794,0.0003399744,0.0006453542,0.0003311778,0.0001311448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2647582,0.042275,0.5969469,0.0006816732,0.001537985,0.00004834783,0.04169651,0.002472081,0.02064574,0.02381014,0.0002717107,0.004855691],"study_design_scores_gemma":[0.85685,0.008268449,0.0890486,0.001451763,0.00005540824,0.00001227251,0.01073483,0.02602129,0.0008589883,0.006227587,0.00003183477,0.0004389432],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927258,0.0006787397,0.0002835834,0.0001907844,0.00005078927,0.004993627,0.00004306844,0.00003558671,0.0009980332],"genre_scores_gemma":[0.9986725,0.0003215795,0.0001967187,0.00006017504,0.00001005705,0.0005891694,0.000064925,0.00002912922,0.00005575875],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5920918,"threshold_uncertainty_score":0.9943617,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2900862674","doi":"10.1007/s40268-018-0255-7","title":"Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly","year":2018,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University","funders":"Institut de Recherches Servier","keywords":"Shake; Perindopril; Medicine; Post-hoc analysis; Observational study; Internal medicine; Post hoc; Cardiology; Engineering; Blood pressure","authors":[{"name":"John S. Sampalis","is_ca":true},{"name":"Eliofotisti Psaradellis","is_ca":false},{"name":"Melissa Stutz","is_ca":false},{"name":"Jenaya Rickard","is_ca":false},{"name":"Emmanouil Rampakakis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06154146838293655,"gpt":0.2998606053313985,"spread":0.238319136948462,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003605375,0.0002063237,0.0007138745,0.00011831,0.0004638012,0.00001868804,0.0001317767,0.0000516198,0.00001025916],"category_scores_gemma":[0.0003868871,0.00009011494,0.00005512817,0.0007377278,0.0007883727,0.00006406839,0.0002917795,0.0001967149,6.531076e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001752077,"about_ca_system_score_gemma":0.00006060434,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004403167,"about_ca_topic_score_gemma":0.003094075,"domain_scores_codex":[0.9985948,0.0001337427,0.0003600976,0.0003330696,0.0003686053,0.0002096727],"domain_scores_gemma":[0.9979702,0.0005212128,0.000142332,0.0003354098,0.0009868698,0.00004394398],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002319566,0.0002278937,0.9139791,0.00007275728,0.003386469,0.00001299862,0.07570365,0.0000653786,0.001022784,0.0002407073,0.001770201,0.001198494],"study_design_scores_gemma":[0.00229772,0.0009462726,0.9817303,0.0003546905,0.001474191,0.000008106439,0.0100716,0.001371181,0.000791526,0.00005467648,0.0007421831,0.0001575939],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875084,0.00238226,0.00000151438,0.008832608,0.00003490287,0.001055101,0.00006922799,0.000009265368,0.0001066817],"genre_scores_gemma":[0.9935129,0.0001376442,0.0001151397,0.005833243,0.00002794247,0.0001187398,0.000005819256,0.00001244277,0.0002360829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06775115,"threshold_uncertainty_score":0.3674781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2083411973","doi":"10.2165/00126839-200607020-00005","title":"Gut Transport of a Molybdenum/Ascorbic Acid Complex","year":2006,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Chromium effects and bioremediation","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Allison University","funders":"","keywords":"Molybdenum; Ascorbic acid; Small intestine; Incubation; Biochemistry; Chemistry; Biophysics; Biology; Inorganic chemistry; Food science","authors":[{"name":"M S Russell","is_ca":true},{"name":"J. Bailey","is_ca":true},{"name":"StephenJ Duffy","is_ca":true},{"name":"Christopher M. Vogels","is_ca":true},{"name":"Tom L. Broderick","is_ca":false},{"name":"Stephen A. Westcott","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00581913416401765,"gpt":0.2082372168515531,"spread":0.2024180826875355,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001289645,0.00006157045,0.00009491632,0.00002444312,0.00001622152,0.000002277176,0.00008922083,0.00003338347,0.0008672577],"category_scores_gemma":[0.000003071379,0.00005374957,0.00004219695,0.0001616896,0.00008586767,0.00005895428,0.00001878352,0.0000431003,0.00008098608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000610659,"about_ca_system_score_gemma":0.000004027971,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0017758,"about_ca_topic_score_gemma":0.0007254989,"domain_scores_codex":[0.9993936,0.000015491,0.0001571623,0.0001282078,0.0001840797,0.0001214875],"domain_scores_gemma":[0.9998142,0.00001481252,0.00004385152,0.0001059711,0.000001857069,0.00001930581],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0000194018,0.0001781535,0.3742024,0.00001951246,0.000002338777,0.000006664714,0.00062559,0.0008905272,0.6183103,0.000264524,0.001372445,0.004108187],"study_design_scores_gemma":[0.0003667471,0.00002383046,0.9779906,0.00000782554,0.000004261235,9.363544e-7,0.00003499084,0.0005155955,0.01955554,0.0003216536,0.001099531,0.00007853955],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911217,0.00001686231,0.00009956068,0.00007585305,0.00004533946,0.000110607,0.000006501285,0.00001184375,0.008511702],"genre_scores_gemma":[0.9992844,0.000003314382,0.0004814781,0.00004165921,0.00003136141,0.000005090934,0.0000238709,0.000004835237,0.0001239502],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6037882,"threshold_uncertainty_score":0.9495863,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211130856","doi":"10.2165/11586020-000000000-00000","title":"Telaprevir","year":2010,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Telaprevir; Ribavirin; Medicine; Pegylated interferon; Pharmacology; Protease inhibitor (pharmacology); Hepatitis C virus; Clinical trial; Virology; Combination therapy; Internal medicine; Virus; Viral load","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0885571778742468,"gpt":0.4554097498599943,"spread":0.3668525719857475,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005692766,0.0002626418,0.001588701,0.0004515428,0.00002105629,0.00001921551,0.0002694675,0.0005868898,0.0009163752],"category_scores_gemma":[0.0005023552,0.0002012179,0.0003222665,0.0004965854,0.00008600423,0.00003231365,0.000128364,0.002169804,0.003191362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001803995,"about_ca_system_score_gemma":0.0006937484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006466659,"about_ca_topic_score_gemma":0.00003065094,"domain_scores_codex":[0.998169,0.0001403813,0.0005145081,0.0003670992,0.0004248952,0.0003840865],"domain_scores_gemma":[0.9987417,0.0002195079,0.00008753807,0.0007293806,0.00004376338,0.0001780964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000001664098,0.00004295652,0.00007651531,0.01179497,0.00002025466,0.0001064001,0.0000390179,2.985719e-9,1.38098e-7,0.00007596351,0.001804109,0.986038],"study_design_scores_gemma":[0.0001881815,0.00002435347,0.00001332477,0.01459914,0.0001105869,0.00002803582,0.000003004587,0.000002339484,5.603638e-7,0.00001470771,0.9848559,0.0001598805],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000872877,0.9016117,0.000001022363,0.00004734255,0.0002306424,0.0009964778,0.00002038853,0.00003958959,0.09704408],"genre_scores_gemma":[0.000003767737,0.9932773,0.0003676144,0.00006145299,0.0003574048,0.0002116144,0.00009988011,0.00007806223,0.005542873],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9858781,"threshold_uncertainty_score":0.9999969,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2579057398","doi":"10.1007/s40268-017-0173-0","title":"A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies","year":2017,"lang":"en","type":"review","venue":"Drugs in R&D","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Meropenem; Dosing; Medicine; Intensive care medicine; Regimen; MEDLINE; Carbapenem; Neutropenia; Internal medicine; Antibiotics; Chemotherapy","authors":[{"name":"Kyle John Wilby","is_ca":false},{"name":"Ziad G. Nasr","is_ca":false},{"name":"Shereen Elazzazy","is_ca":false},{"name":"Tim T Y Lau","is_ca":true},{"name":"Anas Hamad","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2368206627269194,"gpt":0.5424964920427081,"spread":0.3056758293157887,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001769242,0.000384728,0.004725152,0.0001283082,0.00004038016,0.00003313828,0.0003613194,0.0002154556,0.00006623207],"category_scores_gemma":[0.0009412732,0.0002360325,0.0007057993,0.0001987343,0.0002193239,0.00005179719,0.0001149661,0.0008128993,0.00002296693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004871959,"about_ca_system_score_gemma":0.0008987242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004586519,"about_ca_topic_score_gemma":0.00001111433,"domain_scores_codex":[0.9970822,0.0002584374,0.001649019,0.0003900145,0.0003429697,0.000277396],"domain_scores_gemma":[0.9969187,0.0005233406,0.001554386,0.0007236257,0.0001609457,0.0001189876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001699236,0.0003526719,0.001646893,0.1267614,0.0007947941,0.00007980738,0.00002871476,3.690748e-7,3.814752e-8,0.000167834,0.001157774,0.8689927],"study_design_scores_gemma":[0.001101357,0.00008261817,0.0009765508,0.4294794,0.002451067,0.000009127989,0.00001099797,0.000005305028,1.488542e-7,0.000005336301,0.5656738,0.0002043641],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000821135,0.9879986,0.000003905848,0.00009244353,0.000233903,0.0009802439,0.00002515139,0.0000208793,0.01056277],"genre_scores_gemma":[0.0005296741,0.9981954,0.0002549518,0.0002595245,0.0001118305,0.000007629878,0.0001413792,0.0000619698,0.0004376215],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8687884,"threshold_uncertainty_score":0.9625127,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4396608809","doi":"10.1007/s40268-024-00459-5","title":"Retrospective Assessment of Translational Pharmacokinetic–Pharmacodynamic Modeling Performance: A Case Study with Apitolisib, a Dual PI3K/mTOR Inhibitor","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Pharmacodynamics; Pharmacokinetics; Dual (grammatical number); Pharmacology; Medicine; Chemistry; Biochemistry; Signal transduction; Philosophy","authors":[{"name":"Anita Moein","is_ca":true},{"name":"Jin Y. Jin","is_ca":false},{"name":"Matthew Wright","is_ca":false},{"name":"Bruno Alicke","is_ca":false},{"name":"Harvey Wong","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01153475692529791,"gpt":0.3250791939346348,"spread":0.3135444370093369,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003875258,0.0002325767,0.0002285314,0.0001564202,0.00005603334,0.00003172071,0.0001264501,0.00008743082,0.00004520278],"category_scores_gemma":[0.000006029436,0.0002108514,0.0000733994,0.0002970653,0.00007028932,0.00001707407,0.00005486594,0.0002981015,0.000001567288],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001072597,"about_ca_system_score_gemma":0.0003293811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008615388,"about_ca_topic_score_gemma":0.0000494666,"domain_scores_codex":[0.9983668,0.00007890457,0.0003762463,0.0005287592,0.0003866664,0.000262592],"domain_scores_gemma":[0.9995172,0.00001871224,0.00006200102,0.0002131002,0.0001252894,0.00006367126],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.001302894,0.001651988,0.1158263,0.0007501809,0.001249958,0.001785195,0.009283781,0.2816019,0.5789535,0.0001299562,0.0003563368,0.00710795],"study_design_scores_gemma":[0.004079099,0.001741317,0.002650792,0.0002647934,0.0002128467,0.0005569407,0.002026289,0.9573804,0.03021637,0.00002684846,0.0002459153,0.0005983847],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959006,0.0006957387,0.001875788,0.00003977559,0.0004191424,0.0005403901,0.00007854984,0.00002917175,0.0004208285],"genre_scores_gemma":[0.9983637,0.0000645832,0.0008235861,0.00002611547,0.0004255179,0.0001419983,0.00004264733,0.00004851199,0.00006333089],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6757785,"threshold_uncertainty_score":0.859827,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4312064980","doi":"10.1007/s40268-022-00410-6","title":"A Randomised Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Palovarotene Ophthalmic Solution","year":2022,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Altasciences (Canada)","funders":"Ipsen","keywords":"Tolerability; Medicine; Pharmacokinetics; Adverse effect; Placebo; Internal medicine; Anesthesia","authors":[{"name":"William J. Foster","is_ca":true},{"name":"Andrew Strahs","is_ca":false},{"name":"Kent W. Small","is_ca":false},{"name":"James Roach","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03184393169426662,"gpt":0.3427165005340247,"spread":0.3108725688397581,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001208547,0.00009313943,0.0002994632,0.0000641146,0.00009080311,0.000005989376,0.00009854277,0.00001408386,0.00015297],"category_scores_gemma":[0.0000761249,0.00007135413,0.00005319188,0.0002554895,0.0000294041,0.00002288392,0.0001512267,0.0002168706,0.000001606948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000704106,"about_ca_system_score_gemma":0.00005895343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001405135,"about_ca_topic_score_gemma":0.000009305607,"domain_scores_codex":[0.9987363,0.0003106123,0.0003150441,0.0001952815,0.0002960152,0.0001467895],"domain_scores_gemma":[0.9994049,0.0001452922,0.00006160062,0.0002879509,0.00004447012,0.00005580384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05932929,0.0179766,0.6654193,0.0003056435,0.0005352118,0.000266078,0.05292473,0.002340884,0.1512431,0.0001463218,0.0002353554,0.04927749],"study_design_scores_gemma":[0.3249092,0.008241562,0.5709973,0.0001342634,0.000995949,0.00007558747,0.05041346,0.01662884,0.02098507,0.0002872676,0.00560164,0.0007298131],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961125,0.0001988303,0.0001261705,0.001199104,0.0001141366,0.001830234,0.00001663006,0.0000116226,0.0003908029],"genre_scores_gemma":[0.9994409,0.00001904704,0.00008392263,0.0002383578,0.00002393529,0.00009791046,0.000007285303,0.000009935477,0.00007868401],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2655799,"threshold_uncertainty_score":0.2909737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404524533","doi":"10.1007/s40268-024-00496-0","title":"In-Use Physicochemical Stability of Sandoz Rituximab Biosimilar in 0.9% Sodium Chloride Solution After Prolonged Storage at Room Temperature Conditions","year":2024,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Sandoz Canada","keywords":"Relative humidity; Chemistry; Chromatography; Shelf life; Sodium; Humidity; Sodium dodecyl sulfate; Food science; Organic chemistry","authors":[{"name":"Roman Borišek","is_ca":false},{"name":"André Mischo","is_ca":false},{"name":"Tobias Foierl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01396920320488404,"gpt":0.2779864494744776,"spread":0.2640172462695936,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005406609,0.0001952719,0.0004310095,0.0002050675,0.00003290841,0.00001743331,0.0001310681,0.000487477,0.0004815262],"category_scores_gemma":[0.0001437274,0.0001653069,0.000123864,0.0004680948,0.0003206138,0.0001740973,0.0001232735,0.0007410679,0.00003105425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002231353,"about_ca_system_score_gemma":0.00006283211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008029901,"about_ca_topic_score_gemma":0.00030669,"domain_scores_codex":[0.9984079,0.0002680222,0.0004468881,0.0004522908,0.00005389889,0.0003710136],"domain_scores_gemma":[0.9992952,0.000329405,0.00004357601,0.0002711938,0.00003657307,0.00002401067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001136199,0.0008708874,0.01243727,0.0001814925,0.00005079397,0.00005128033,0.001162299,0.000001880407,0.9814063,0.000290962,0.002276374,0.0001342547],"study_design_scores_gemma":[0.002410499,0.00008483924,0.04662582,0.0002946524,0.00004263612,0.00001292251,0.0001523527,0.0001399313,0.9450877,0.000935937,0.003920209,0.0002925273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947198,0.002041424,0.000006819786,0.001995102,0.000489153,0.0003358334,0.0002839361,0.00003053384,0.00009741291],"genre_scores_gemma":[0.9990714,0.00006156586,0.0001505803,0.000301684,0.00003180692,0.00008150104,0.00007896857,0.00001344724,0.0002090596],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03631863,"threshold_uncertainty_score":0.6741021,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W27770296","doi":"10.1007/s40268-016-0139-7","title":"Types of Support Accessed by Families of Young Children with Disabilities Living in Alberta.","year":2004,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Family and Disability Support Research","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Psychology; Sample (material); Family income; Gerontology; Developmental psychology; Medicine; Economic growth","authors":[{"name":"Jane Drummond","is_ca":false},{"name":"Linda McDonald","is_ca":false},{"name":"Sandra MacKenzie-Keating","is_ca":false},{"name":"Darcy Fleming","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01601996718566453,"gpt":0.3137259607633713,"spread":0.2977059935777068,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004315926,0.0001377366,0.0003335399,0.0001655849,0.00001759789,0.000008687701,0.0002988894,0.0001057239,0.0008476716],"category_scores_gemma":[0.0002583707,0.0001182008,0.00004835913,0.000403995,0.0005211732,0.0001433696,0.00007390001,0.0001916529,0.00002621753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005883052,"about_ca_system_score_gemma":0.0001098075,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.06234437,"about_ca_topic_score_gemma":0.01556044,"domain_scores_codex":[0.9985654,0.0001006717,0.0004336932,0.0003029383,0.0002572135,0.0003400213],"domain_scores_gemma":[0.9989026,0.000530283,0.00007440414,0.0004068168,0.000040446,0.00004550782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001113985,0.0007134225,0.9645601,0.00007279363,0.00003105832,0.000001078523,0.03199171,0.00006575316,0.0001273258,0.001667594,0.0002008094,0.0004569362],"study_design_scores_gemma":[0.0008705408,0.0002021223,0.9576483,0.00009493786,0.000007198075,0.000003542885,0.03878872,0.000002256778,0.001543751,0.0006747063,0.00002357366,0.0001403205],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9669734,0.0001008259,0.00000581248,0.0001190535,0.00005950191,0.0002822553,0.00003449508,0.00001041483,0.03241429],"genre_scores_gemma":[0.9989101,0.00001441742,0.0000554477,0.00002586749,0.00001164044,0.00004518607,0.00003300833,0.000016343,0.0008880096],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04678393,"threshold_uncertainty_score":0.9438996,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4249646940","doi":"10.1007/bf03262369","title":"Food Effects on the Pharmacokinetics of Doxylamine Hydrogen Succinate 25 mg Film-Coated Tablets","year":2012,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Pharmacokinetics; Pharmacology; Bioavailability; Antihistamine; Crossover study; Medicine; Chemistry; Placebo","authors":[{"name":"Sebastián Videla","is_ca":false},{"name":"Mounia Lahjou","is_ca":true},{"name":"Pascal Guibord","is_ca":true},{"name":"Zhengguo Xu","is_ca":false},{"name":"Carles Tolrà","is_ca":false},{"name":"Gregorio Encina","is_ca":false},{"name":"Éric Sicard","is_ca":true},{"name":"Artur Sans","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01396631661582227,"gpt":0.2747078549690658,"spread":0.2607415383532435,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002559407,0.000163805,0.0002646104,0.00009401717,0.00003479921,0.000003938312,0.00009738095,0.00006686913,0.0000773096],"category_scores_gemma":[0.0001262187,0.0001039849,0.00006261856,0.0002640052,0.00003416717,0.00003950866,0.00003827911,0.0001818773,0.00006755468],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006771216,"about_ca_system_score_gemma":0.00002112306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004687663,"about_ca_topic_score_gemma":0.000001798491,"domain_scores_codex":[0.9989864,0.00008286253,0.0001968717,0.0001399196,0.000237784,0.0003561988],"domain_scores_gemma":[0.9991917,0.0003167262,0.00007881895,0.0002889321,0.00002815563,0.00009566594],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004873308,0.00830297,0.6914225,0.001749433,0.002430339,0.0002424481,0.01928309,0.000301394,0.2098105,0.004246226,0.01845161,0.03888622],"study_design_scores_gemma":[0.00524741,0.001250409,0.06899366,0.0004465352,0.0002011022,0.00001252812,0.0001000702,0.0006773248,0.9197122,0.0000580702,0.003140401,0.0001602704],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906282,0.0008166847,0.000001945291,0.0004585057,0.0002097838,0.000399228,0.00001440017,0.00003670689,0.007434582],"genre_scores_gemma":[0.9985839,0.00005197158,0.0000436912,0.00045244,0.0001106893,0.00003187892,0.00002599876,0.00002477685,0.0006746156],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7099018,"threshold_uncertainty_score":0.4240382,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411554374","doi":"10.1007/s40268-025-00514-9","title":"Demonstrating Bioequivalence for a Lumacaftor Monosubstance Formulation Versus Orkambi® (Lumacaftor/Ivacaftor) in Healthy Subjects","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ted Rogers Centre for Heart Research; Heart and Stroke Foundation; Micropharma (Canada); University of Toronto","funders":"","keywords":"Ivacaftor; Bioequivalence; Medicine; Pharmacology; Pharmacokinetics; Internal medicine","authors":[{"name":"Alexandra Papaelias","is_ca":true},{"name":"Darcy Lidington","is_ca":true},{"name":"Steffen‐Sebastian Bolz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03127630825639068,"gpt":0.3832231826700569,"spread":0.3519468744136663,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006782594,0.0002280405,0.0004459351,0.0005466835,0.0001089309,0.00003678699,0.0002141498,0.0001517987,0.00002173392],"category_scores_gemma":[0.001743696,0.0002377615,0.00009246711,0.001140688,0.0000992526,0.0002823333,0.0000683077,0.0003914371,0.000009610481],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008081719,"about_ca_system_score_gemma":0.0005235827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002332567,"about_ca_topic_score_gemma":0.000297721,"domain_scores_codex":[0.9975387,0.00007628113,0.0006600523,0.0005616605,0.0004141593,0.0007491717],"domain_scores_gemma":[0.9980255,0.001185323,0.0001246435,0.0003796321,0.0001427874,0.0001421365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06310673,0.001423995,0.6858665,0.006514136,0.0001667714,0.0001154806,0.002047712,0.001139414,0.04529911,0.02187341,0.002699652,0.1697471],"study_design_scores_gemma":[0.07859576,0.005396775,0.702993,0.008763204,0.0001574344,0.00002005559,0.006770739,0.1340855,0.03198981,0.01197426,0.01749811,0.001755389],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900388,0.00197538,0.00221012,0.0007623309,0.0002313624,0.001795751,0.00002248136,0.00007741657,0.002886347],"genre_scores_gemma":[0.9840246,0.0001771822,0.01477465,0.0001875983,0.0001038315,0.0003924967,0.00003807397,0.0000259146,0.0002755846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1679917,"threshold_uncertainty_score":0.9695634,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411698938","doi":"10.1007/s40268-025-00515-8","title":"In-Vitro Comparison of Physical Characteristics, Enzyme Content, and Release Kinetics of Pancreatic Enzyme Preparations Available in Europe and Canada","year":2025,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Pancreatic enzymes; Enzyme; Enzyme kinetics; Kinetics; In vitro; Chemistry; Biochemistry; Food science; Physics","authors":[{"name":"Sven Hartmann","is_ca":false},{"name":"Jonas Rosendahl","is_ca":false},{"name":"Amy Todd","is_ca":false},{"name":"Emma Bennett-Huntley","is_ca":false},{"name":"J. Enrique Domínguez‐Muñoz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01639224360986564,"gpt":0.2781121794221753,"spread":0.2617199358123096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006011533,0.00008898898,0.0004745655,0.0001061162,0.000009581599,0.000002016867,0.00002722356,0.00003826286,0.000008230425],"category_scores_gemma":[0.000205585,0.00008348352,0.00001068285,0.0001592004,0.0001051249,0.00002422925,0.00002776267,0.0001113334,9.571328e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005949067,"about_ca_system_score_gemma":0.000152668,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.06799307,"about_ca_topic_score_gemma":0.04969466,"domain_scores_codex":[0.9992752,0.00006712478,0.0003181722,0.0001547066,0.0000695462,0.000115225],"domain_scores_gemma":[0.9995044,0.0001896575,0.00007842781,0.0001413552,0.0000503651,0.0000358131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003689499,0.0007964702,0.9534395,0.0002330025,0.00003856413,0.00009927174,0.001156468,0.000007003388,0.04215397,0.0007024128,0.0007343576,0.0002700288],"study_design_scores_gemma":[0.002920093,0.0002159433,0.8751831,0.0004048641,0.0001224254,0.000007980851,0.0002641128,0.001956874,0.1182712,0.00004342492,0.0005268478,0.00008311189],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961182,0.0009741315,0.000006281649,0.0001814555,0.00003388242,0.0002416752,0.00005118135,0.000002917815,0.002390313],"genre_scores_gemma":[0.9987456,0.0001594516,0.0001402053,0.00007629687,0.000008045286,0.00001856873,0.0000347513,0.000004587273,0.000812482],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07825639,"threshold_uncertainty_score":0.9676459,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}